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CARDIOLOGY
MYOCARDIAL SPECT IN LEFT BUNDLE BRANCH BLOCK
K. Zupán1, B. Kári2, O. Pártos1
1Gottsegen György Hungarian Institute of Cardiology,
2Semmelweis University, Department of Diagnostic Radiology and Oncotherapy
 On myocardial perfusion SPECT (MPS) images, the frequently observed perfusion
defect in the septal region without organic coronary stenosis in patients with left
bundle branch block (LBBB) reduces the accuracy of the diagnosis of coronary
artery disease (CAD). The aim of our study was to enhance the specificity by using
a “disease-specific” reference database containing data of patients with LBBB and
a low likelihood of CAD. MPS images of 170 patients with LBBB, studied between
1997 and 2003, were re-evaluated. Of patients imaged with Tl-201, 50 underwent
coronary angiography (CAG) within 6 months of the perfusion study. Reconstruct-
ed polar maps were compared to a database of images of 14 patients with LBBB,
who were retrospectively considered to have a low likelihood of CAD. Diagnostic
performances were assessed with ROC analysis. Our method discriminates pa-
tients with CAD well from those without this disease (area under the ROC curve:
0.86 ± 0.05, while using a commercial, validated expert system we get: 0.63 ±
± 0.08, p < 0.05). The use of a normal database constructed of patients with LBBB
improved the specificity of diagnosing myocardial ischaemia on MPS images in
our patient group.
PITFALLS IN THE EVALUATION OF STREES/REST
MYOCARDIAL PERFUSION SPECT EXAMINATION
K. Zámbó, E. Udvaros, Z. Szabó, E. Schmidt
University of Pécs, Medical Faculty, Department of Nuclear Medicine
Aim: Estimate of the diagnostic value of the stress/rest myocardial perfusion SPECT
study and correction of the pitfalls of this method.
Material and methods: The examinations were performed by Cardio-C (Mediso),
with two fixed detectors in 90 degree, 180 degree rotation, 32 step, 70 seconds time
option by step. Coronarography was the reference method to comparison results.
Results: Correspondence of the findings was found at the most of the examina-
tions, but fals-negative and fals-positive results are also obtained in some cases.
Technical problems are playing role between the causes of that, but the special
status of the coronary circulation and other heart diseases could modify the results,
too. The reverse redistribution (Thallium) and reverse perfusion (MIBI) needs a spe-
cial evaluation and explanation.
Conclusions: The adequate indication and the correct preparation of the patients,
the suitable equipments and the consensus of the different experts is very impor-
tant in the improvement of the diagnostic value.
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COMPARISON OF THE RESULTS OF INTRACORONARY
PRESSURE MEASUREMENT AND STRESS SCINTIGRAPHY
Z. Kõszegi1, C. Jenei1, J. Varga2, L. Galuska2, I. Édes1
1University Medical School of Debrecen, Department of Cardiology
2Department of Nuclear Medicine
Background: The myocardial ischemia caused by a stenosis of the coronary artery
can be assessed by nuclear perfusion study while the epicardial flow limitation can
be measured by intracoronary pressure measurement. The 0.75 value of the frac-
tional flow reserve (FFR) was established as the cut off value for reversible perfusion
defect on the stress SPECT examination, but the correlation of the FFR values and
the number of segments with reversibility of the perfusion defects has not deter-
mined.
Aim: to compare the perfusion defects obtained by stress MIBI SPECT with the FFR
values detected by intracoronary pressure measurements concerning the related
myocardial segments supplied by the stenotic coronary artery.
Material and methods: We used the echocardiographic 17 segments polar map
to represent the left ventricle. The FFR were measured by pressure wire in 21 coro-
nary arteries of 17 patients (9 with prior AMI). The associated 130 segments were
projected on the left ventricular polar map. The rate of the segments with reversibil-
ity within the region supplied by the stenotic coronary artery (i.e. the number of
segments with reversibility divided by the number of supplied segments associated
with the measured lesion) and the number of segments with reversibility were com-
pared with the FFR.
Results: The rate of the segments with reversibility found to be correlated better
with the FFR values (r = –0.57, p = 0.006), than the number of segments alone
(r = –0.48, p = 0.03).
Conclusion: During vasodilatation the translesional gradient determines the rate of
reversibility of the perfusion defects within the supplied region. For clinical evalua-
tion it seems to be useful to consider the lesion associated segments together with
the FFR.
HOLISTIC POLAR MAP FOR INTEGRATED EVALUATION
OF CARDIAC IMAGING RESULTS
Z. Koszegi1, L. Balkay2, E. Balogh1, J. Varga3, L. Galuska3,
T. Fulop1, E. Kristof1, I. Hegedus1, I. Edes1
1University of Debrecen, Institute of Cardiology
2PET-Centre
3Department of Nuclear Medicine, Debrecen
To assess the myocardial territory associated with a coronary lesion, an Access
based software was developed for translation of the coronary artery tree into a polar
map (PM). The wall motion scores of the 17 left ventricular segments on the echocar-
diograms were projected also into the “holistic” PM by the same principles as for
the nuclear medicine studies.
The generated PMs of the coronary angiography were compared with „real” 99Tc-
-labelled MIBI single photon emission computed tomography (SPECT) PMs in or-
der to test the accuracy of the localizing method. The overlap between the predict-
ed segments associated by the coronary lesion and the stress perfusion defects
(< 80% relative MIBI activity during stress test) was analyzed in the 10 patients after
myocardial infarction with a (sub)total coronary occlusion. Furthermore the resting
segmental wall motion scores were also integrated on the same PM. The distribu-
tion of the total of 170 segments with stress perfusion defects on MIBI SPECT and
the rest wall motion abnormalities detected by echocardiography gave positive and
negative predictive values of coronary occlusion of 0.94 and 0.81 against SPECT,
and 0.82 and 0.76 against echocardiography, respectively.
While the distal part of the subtended territory always showed higher degree perfu-
sion abnormality than the proximal one, the high positive predictive value proved
that during the stress condition the perfusion defect could be detected practically
all the subtended regions. The low negative predictive value of the coronary lesion
for the wall motion abnormality was associated to the remodeling of the entire left
ventricle.
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PULSE-PRESSURE PREDICTS TRANSIENT MYOCARDIAL PERFUSION
ABNORMALITIES DURING DIPYRIDAMOLE STRESS TEST
Z. Szabó1, T. Molnár2, T. Szakmány2, E. Udvaros1, E. Schmidt1,
A. Cziráki3, K. Zámbó1
1Department of Nuclear Medicine
2Department of Anesthesiology and Intensive Therapy
3Heart Centre University of Pecs, Faculty of Medicine, Hungary
Background: There is now increasing evidence that high pulse pressure (PP) is an
indicator of large artery stiffness and an independent risk factor of cardiovascular,
especially coronary mortality (1). In this study we investigated the relationship be-
tween the pulse pressures measured during intravenous dipyridamole (DP) stress
test and the results of myocardium perfusion scintigraphy (MIBI) in patients with
suspected coronary artery disease.
Material and methods: Study design: retrospective analysis. Patients: 142 con-
secutive out-patients, who were scheduled for MIBI by cardiologists in 2004. Each
patient was routinely monitored (12 leads ECG records, ECG monitor, NIBP mea-
sured on the upper arm) during the DP test. Measurements were performed prior to
test as baseline (heart rate = HRb, systolic = SBPb, diastolic = DBPb, and PPb),
during the DP administration and at the end of 4 min (…., PP4). Thereafter MIBI
examination was performed. For statistical analysis ROC and chi-square tests were
used with SPSS 11.5.
Results: 142 patients (male: 56, female: 86) were recruited to the study. Mean ±
± SD values of female vs. male patients were the following: Age: 54 ± 8.1 vs. 57 ±
± 11.3 years. Weight: 76 ± 14.5 vs. 84 ± 8.7 kg. SPB: 147 ± 26.1 vs. 152 ± 18.0 mm Hg.
DBP: 85 ± 8.8 vs. 90 ± 10.6 mm Hg. PPb: 63 ± 18.1 vs. 62 ± 14.1 mm Hg, PP4:
63 ± 17.3 vs. 63 ± 15.8, MIBI pos.: 30 vs. 31, respectively. In obese male patients
(kg > 80) we found that PP4 ≥ 60 mm Hg indicates transient myocardial perfusion
abnormalities (positive MIBI) with a sensitivity 80% and specificity 70% (AUC: 0.792,
p < 0.05). Significantly more frequent positive MIBI tests were found in patients with
PP4 ≥ 60 mm Hg in this high-risk group (p < 0.01). However, in obese female
patients (kg > 65) PP4 was not a reliable predictor of positive MIBI examination
(AUC: 0.673, 55.2%, 58%, NS, respectively).
Conclusions: In multi-risk patients (male, obesity) a high PP4 may indicate transient
myocardial ischemia detected by MIBI examination, which has a diagnostic impor-
tance regarding the coronary morbidity. Our results are supported by studies which
emphasize the high pulse pressure as a strong predictor for cardiovascular mortal-
ity (2). Further prospective examinations are warranted in a larger patient popula-
tion, stratified according to the body mass index (BMI).
7
EVALUATION OF MYOCARDIAL STUNNIG BY ECG GATED MYOCARDIAL
PERFUSION SPECT
O. Pártos, K. Zupán
Gottsegen György Hungarian Institute of Cardiology, Budapest
Myocardial stunning (MS) is characterised by delayed functional recovery after tran-
sient ischaemia. ECG gated myocardial perfusion SPECT (G-SPECT) detects myo-
cardial perfusion and function simultaneously. 27 patients with suspition of MS were
selected out of a larger patient group referred for assessing myocardial ischaemia
by G-SPECT. Myocardial segments with over 70% of the maximal perfusion activity
were considered as good perfused ones. Segmental perfusion, wall motion and
wall thickening were evaluated (Mediso InterwiewR and Emory Cardiac ToolboxR).
Perfusion and functional data were correlated with the localisation and severity of
coronary stenoses assessed by coronarography. 59% of the segments showing
good resting perfusion with functional deficit were perfused by stenosed coronary
arteries while only 40% of those without functional deficit (p < 0.01). In segments
without transient ischaemia, the difference was more pronounced (p < 0.001).
Presence of MS based on G-SPECT evaluation in segments with equivocal signs of
transient ischaemia reinforces the evidence of ischaemia. MS in segments without
transient ischaemia gives evidence of the stenosis of the corresponding coronary
artery.
6
THE PREDICTIVE VALUE OF I-131-MIBG AND TL-201
SCINTIGRAPHY FOR HIGH RISK OF CARDIAC DEATH
I. Balogh1, E. Marosi1, E. Zima2, J. Környei3, B. Merkely2
Uzsoki Street Teaching Hospital, Department of Nuclear Medicine, Budapest
1National Center of Health, Department of Cardiology and Internal Medicine,
Budapest
2Semmelweis University Faculty of Medicine, Department of Cardiovascular
Surgery, Budapest
3Isotope Institute, Budapest, Hungary Arrhythmias, MIBG-scintigraphy
Implantable cardioverter defibrillator
Backgroung: The damage of sympathetic innervation (SI) and resulting increased
circulating catecholamine concentration may be responsible for malignant ventric-
ular tachyarrhythmias (MVT). The implantable cardioverter defibrillator (ICD) is both
a therapeutic modality for the pts with MVT preventing arrhythmias and a ”detector”
registrating continously the frequency and severity of MVT.
Our question was: is there any connection with the severity of the damage of SI
”measuring” by MIBG scintigraphy (MIBG-Sc), and the myocardial perfusion de-
tecting Tl-scintigraphy (MSc) and the clinical risk registered by ICD?
Material and methods: We examined (18 patients) with ICD, 10 patients after my-
ocardial infarction (CAD), 8 patients with idiopathic cardiomyopathy (DCM). We
performed in every case Tl-Sc and MIBG-Sc. On MIBG-Sc we analysed the diffuse
MIBG uptake measuring the mediastinal/heart ratio and the regional abnormality.
On Tl-Sc we analysed the severity, the extension of the perfusion abnormality. We
compared the findings on MIBG and Tl-Sc (”mismatch”) and all of these with ICD
registration (frequency and duration of MVT).
Results: In the group of CAD, MIBG uptake was diffusely lower than the normal
valne in 8/10 patients, regional abnormality were in 10/10 patients, Tl-Sc showed
regional abnormality in 10/10 patients. Comparing the MIBG-Sc and Tl-Sc ”mis-
match” was detected in 10/10 patients and in 3 clinically severe cases the ”mis-
match” were the greatest.  In the group of DCM pts the MIBG uptake showed both
diffuse and regional abnormality in 8/8 patients. On Tl-Sc we could detect inho-
mogenity in 8/8 patients. ”Mismatch” could be found in 8/8 cases, most severely in
the 3 cases with severe findings on ICD registration.
Conclusion: In all patients with ICD, registered different severity of MVT, the dam-
age of SI was verified. The ”mismatch” between MIBG-Sc and Tl-Sc could be found
as well. The most severe MIBG positivity, and the most expressed ”mismatch” as-
sociated with the most severe clinical signs on ICD registration. Thus the severity of
the damage of SI and the expressivity of the perfusion and SI ”mismatch” may have
a high prognostic value.
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EXAMINATION OF MYOCARDIAL VIABILITY BY DIFFERENT
NON-INVASIVE METHODS (CASE REPORT)
E. Marosi1, I. Balogh2, T. Simor3, P. Andrássy1, K. Hüttl1, I. Préda1
1National Center of Health, Department of Cardiology and Internal Medicina
2Uzsoki Street Teaching Hospital, Department of Nuclear Medicine, Budapest
Myocardial viability, diagnostic techniques
Detecting the viable myocardium several diagnostic techniques can be used. The
purpose of our current study is to compare these methods. Patients after myocar-
dial infarction and before revascularization are examined with contrast enhanced
cardiovascular magnetic resonance imaging, rest redistribution Tl-201 and nitrate
administrated gated Tc-99m MIBI myocardial scintigraphy, 2-D and dobutamine
stress echocardiography. We intend to repeat these examinations after revascular-
ization. At this time one case is shown.
The 61-year-old patient had a history of anterior myocardial infarction, hyperten-
sion, diabetes mellitus. Because of angina pectoris he underwent coronary angiog-
raphy which proved severe left main stenosis and three-vessel disease (occl.LAD,
sten.Dl, sten.OM, occl.RCA). All of the non-invasive diagnostic techniques showed
necrosis in the greater part and hibernation in the smaller part or in the territory of
the left anterior descending coronary artery. In the territory of the right coronary
artery small size of hibernation was detected. During the coronary bypass surgery
four vein and one artery bypass grafts were implanted. After the operation the pa-
tient was asymptomatic, with high work capacity and without angina pectoris. We
experienced improvement of function and perfusion in the myocardium had been
considered viable.
Likewise other evidences this case verifies that all of these examinations are capa-
ble to identify hibernating myocardiu. After examined all of the planed number of
patients we can evaluate the diagnostic value of these methods.
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LYMPHOSCINTIGRAPHY IN PATIENTS WITH CHRONIC
VENOUS INSUFFICIENCY
Z. Besenyi1, 3, G. Szolnoky2, M. Papós1, 3, T. Séra1, 3, 4, J. Julesz4, A. Dobozy2,
L. Kemény2, L. Pávics1, 3
1IMC Szeged
2Department of Dermatology and Allergology
3Department of Nuclear Medicine
4Department of Endocrinology, University of Szeged, Szeged, Hungary
 Aim: To evaluate of the lymphatic flow abnormalities by lymphoscintigraphy (LS) in
patients with severe stages of chronic venous insufficiency (phlebolymphedema,
leg ulcer).
Material and methods: LS was performed in 68 patients with clinically suspected
secondary lymphedema. Thirty-eight patients had chronic venous insufficiency
(group A) and 30 leg ulcer with venous-origin (group B). A normal value was calcu-
lated on the basis the LS results in 10 normal extremities (control group). In patients
with pathological LS side difference score (SDS) was also calculated and in the
group B SDS was compared with the clinical edema score (CES).
Results: In group A LS revealed decreased lymphatic flow in 32 patients (84%) and
was normal in 6 cases (16%). The disease was bilateral in 24 cases without any
clinically proven side difference, although LS showed side difference in 15 of them
(62%). In group B in 26 cases (87%) LS showed abnormal finding and was normal
in 4 cases (13%). In 5 cases without clinical evidence of asymmetry, with LS side
difference was verified. In the group B patients with unilateral disease SDS showed
significant, although weak and negative correlation with CES (r = –0.3, p < 0.02)
suggesting relatively increased lymphatic flow.
Conclusion: LS can be helpful to clarify the characteristics of the secondary lymphe-
dema. In group A the results of LS give additional information for reconsideration of
classification and therapy planning. In the unilateral leg ulcer group increased lym-
phatic flow might be a compensation of decreased venous flow.
ANGIOLOGY
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EFFICACY OF 123I-FP CIT (DATSCAN) SCINTIGRAPHY IN GENERAL
NEUROLOGICAL DISTRICT DEPARTMENT AND IN SPECIALIZED
MOVEMENT DISORDERS CENTER
P. Koranda1, J. Bakala2, K. Kupka3, H. Krížová3
Departments of Nuclear Medicine:
1Palacký University Olomouc
2Bat’a Hospital, Zlín, Czech Republic
3Charles University Prague, Department of Nuclear Medicine
Aim: 123I-FP CIT (DaTSCAN) scintigraphy is indicated for detecting loss of func-
tional dopaminergic neuron terminals in the striatum of patients with clinically un-
certain Parkinsonian Syndromes, in order to help differentiation of Essential Tremor
from Parkinsonian Syndromes related to idiopathic Parkinson´s Disease, Multiple
System Atrophy and Progressive Supranuclear Palsy. It enables to diagnose Par-
kinsonian Syndromes early in incipient phases of these diseases. The aim of our
study coordinated by VZP/General Health Insurance Company/was to evaluate all
benefits of this investigation under different conditions of general neurological dis-
trict department and specialized movement disorders center.
Material and methods: All patients were examined 3 hours after i.v. administration
of 185 MBq 185 MBq 123I-FP CIT using dual-head SPECT gamma cameras. Basic
visual evaluation was supported by semi quantitative one. The indexes of specific
activity  (ISA) of the tracer in  nc. caudatus (NC), putamen (P) and striatum (S) for
the left and right hemisphere were calculated: ISA = (ROI-crbl)/crbl (ROI = counts
in the evaluated region, crbl = counts in cerebellum with nonspecific accumulation
of radiopharmaceutical only).
Results: The diagnoses of movement disorders were confirmed due to 123I-FP CIT
scintigraphy in 57%, specified in 27% and changed in 16% of patients examined
and treated at general neurological department. The results in highly selected group
of patients treated at the specialized movement disorder center were similar and
diagnoses were confirmed approximately in 60%, specified in 30% and changed in
10%.
Conclusion: 123I-FP CIT scintigraphy is helpful in selected patient group of pa-
tients with movement disorders treated not only at general neurological district de-
partment but also at specialized movement disorder center. In some cases when
123I-FP CIT is able to exclude false positive diagnosis of Parkinsonian Syndromes,
the scintigraphy could bring direct economical benefit due to elimination of unnec-
essary medical treatment.
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ECONOMIC IMPACT OF PARKINSONCS DISEASE
— THE IMPORTANCE OF EARLY AND CORRECT DIAGNOSIS
A. Takáts
Semmelweis University, General Faculty of Medicine, Department of Neurology
Parkinson’s disease is the second most common chronic, progressive, degeneraive
neurological disorder, characterized by slowness of movements, rigidity, tremor
and postural instabilty. The occurence in the population above 65 years may be ten
time higher than under 65. About 4 million people are suffering from this disease all
around the world, 1 million in the USA. In the UK 120 000 patients have been regis-
tered, where 1 of every 20 patient is under 40 year. Paralell with the the increase of
the age four times more patients are estimated by 2040 in the USA. The yearly
increase of prevalence above 70 years is about 2%.
The cost of the therapy in UK is calculated 560 000 — 1 million pounds/year/100
000 inhabitants. Parkinsoncs disease appears to be one of the ”most expensive”
disease in Germany, as well.
The costs will be increased by the occurence of motor fluctuation, psychosis and
other complications. More and more studies report that the so-called indirect costs
in the late stages of the disease are much higher than the ”active”-pharmaceutical
treatment.
The incidence and prevalence  of Parkinsoncs disease is similar all around the
world. According to some estimated data about 20 000 PD patients might be taken
into account in Hungary, and further 1500–2000 new patients (de novo) are to be
registered. To establish an early and correct diagnosis of PD is essential. The role of
dopamine transporter imaging in the diagnostic work-up is of great importance.
These methods helps:
— to estimate the preclinical nigrostriatal terminal dysfunction;
— to support diagnosis with early disease;
— to support differential diagnostic problems;
— to monitor disease progression.
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COMPARISON OF THE SPECT INVESTIGATIONS PERFORMED
WITH STRIATAL PHANTOM
Z. Besenyi1, 2, T. Séra1, 2, 3, M. Árgyelán2, B. Kanyó2, J. Julesz3, L. Kardos1,
L. Pávics1, 2
1International Medical Center, Szeged
2Department of Nuclear Medicine
3Department of Endocrinology, University of Szeged, Szeged, Hungary
 Aim: The aim of this study was to investigate the intra- and interobserver variability
of the visual and semiquantitative evaluation of the striatal SPECT phantom images.
Material and methods: The three-dimensional, tissue-equivalent phantom was al-
ternatively filled with 123I and 99mTc radioisotopes, respectively (rest brain compart-
ment: 5 kBq/ml, striatal compartment: 25 kBq/ml). Images were performed on three
SPECT devices, using the same protocol. The phantom was investigated on an MR
equipment as well. Images were evaluated by three independent observers. The
ratios of the frontal and occipital striatal regions were semiquantitatively determined
using the ROI technique, based on MR images.
Results: There were no differences between the visual results. From the three differ-
ent SPECT investigations, the ratio of the dispersions and medians, in percentage
was found to be: 8,15/9,5/7,5% for 99mTc; and: 9.8/11.5/8.1% for 123I, respectively.
Conclusion: The visual and the semiquantitative analysis proved to be perfectly
reproducible. There was no correlation between the results, and the investigator,
the equipment type, or the used radioisotope.
NEUROLOGY
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RCBF CHANGES IN PARKINSONIAN PATIENTS WITH DEMENTIA
M. Derejko1, P. Lass1, J. Sławek2, M. Dubaniewicz3
1Department of Nuclear Medicine
2Department of Movement Disorders, Department of Radiology,
Medical University, Gdańsk, Poland
Background and aims: Dementia is 2–6 fold more frequent in Parkinson’s disease
patients than in controls. It presents a number of diagnostic problems due to the
lack of standard diagnostic criteria, bradyphrenia, side effects of therapy and con-
comittant depression.  Psychometric testing meets difficulties. The aim of the study
is to evaluate cerebral blood flow changes in Parkinsonian demented patients as
well as to evaluate rCBF SPECT scanning as a diagnostic tool in this group of pa-
tients.
Material and methods: 44 patients with Parkinson’s disease (PD) were enrolled in
the study: non-demented (11 patients), with mild cognitive impairment (20 patients),
demented ones (13 patients); control group were grupę kontrolną stanowiło 20
zdrowych ochotników. rCBF SPECT scanning hads been performed using 99mTc-
-HMPAO (Amersham, UK) i and a triple-head gammacamera MS-3 (Siemens, Ger-
many). We evaluated inter-hemispheric asymmetries using asymmetry index (AI)
and regional cerebral perfusion using cerebellar normalisation.  MRI scanning has
been performed using 0.5 T device Gyroscan (Philips, Holland) and ARWMC scale.
Results: PD patients had a lower cerebral perfusion in all cerebral areas except
thalami and basal ganglia. PD patients with dementia additionally had more pro-
nounced temporal and occipital hypoperfusion. A number of focal perfusion defi-
cits in PD demented patients was higher than those without dementia in left, but not
right hemisphere. MRI results were not contributory to differental diagnosis of de-
mentia in PD patients.
Conclusions: those results may suggest a mixed: neurodegenerative and cere-
brovascular etiology of dementia. rCBF SPECT scanning may be useful in diagno-
sis of cognitive impairment in PD patients.
16
NON-PARAMETRIC STATISTICAL ANALYSIS
OF BRAIN SPECT- AND PET STUDIES
M. Emri1, S. Szakáll1, D. Glaub2, J. Molnár3. L. Trón1
1University of Debrecen Medical and Health Science Center, PET Center
2 University of Debrecen Medical and Health Science Center, Institute of
Psychiatry
3Institute of Nuclear Research of the Hungarian Academy of Sciences
 A large amount of gray matter can be excluded from the statistical parametric ana-
lysis of  brain SPECT- and PET images because of inadequate F-statistics. This
problem may be solved by time consumption of robust non parametric tests. To
meet this challenge, we elaborated a voxel-based non-parametric software pa-
ckage running on a computer cluster for the statistical analysis of our clinical projects.
This program reads input data from the primary SPECT or PET images or the ad-
justed volumes generated by the SPM tools, as well. The current version is suitable
for the analysis of the correlation between brain images and physiological parame-
ters or finding the functionally correlated areas. In the case of population compari-
son it is useable to compare two or more populations or investigate the effect of any
treatment on the same population.
The program was checked by perfusion and FDG-PET studies relating to group
comparison and functional correlation analysis.
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FULLY AUTOMATIC DELINEATION OF STRIATUM IN DOPAMINE SPECT
INVESTIGATIONS
M. Árgyelán, B. Kanyó, Z. Besenyi, Á. Füle, L. Pávics
Department of Nuclear Medicine, University of Szeged, Szeged, Hungary
Objectives: The number of performed SPECT investigations with pre- and post
synaptic dopaminerg ligands are increasing. In the majority of cases the semiquan-
titative evaluation of these studies are based on fixing basal ganglia ROIs manually.
There are different efforts in the nuclear medicine community to make these evalu-
ations fully automatic. This can be achieved by registering the images into the MNI
space and masking areas with predefined MNI VOIs. However due to the inevitable
errors of registrations in cases of small VOIs (like striatum) the results can be mis-
leading. (Fig. 1. method 2) The aim of our study was to introduce an automatic
method that can consider and correct errors deriving from misregistration.
Material and methods: 11 healthy individuals underwent a 99mTc-TRODAT SPECT
investigation. Three methods were tested: 1. traditional manually fixed ROIs; 2. re-
gistration images into MNI space, and standard VOIs (number of voxels: 2815,
WFU Pickatlas) were fixed on striatum; 3. On the registered images dilated VOI
(WFU Pickatlas, 4 voxels dilatation of original striatum) masked striatum. The in-
creased VOI was then narrowing by a special smoothing algorithm in order to pre-
cisely delineate the suspected striatal area (the final size of VOI became 2815 voxel
also) (Fig. 1. method 3). In the latter two methods the same predefined occipital VOI
(voxel size: 7466) was used. The reliability was estimated by test-retest variability
(TRV) and intraclass correlation coefficient (ICC). In these normal cases the gold
standard was the method 1.
Results: In case of striatum VOIs: comparing the method 2 with the method 1 the
TRV was 21 ± 9% (mean ± SD), ICC was 0.92 (0.73–0.98) (95% CI ), while compa-
ring method 3 with method 1 TRV was 15 ± 8%, ICC was 0.96 (0.88–0.99). The
method 3 always overestimated the method 1, while method 1 always overestimat-
ed method 2. In the case of occipital cortex: TRV was 13 ± 8%, ICC was 0.96 (0.87–
–0.99). There was no significant difference in the mean values of the automatically
and manually fixed occipital masks.
Conclusion: The evaluation shows that our method (method 3) can improve the
reliability of our results in the case of small areas like striatum, while using larger
masks (like occipitum) the automatic and manual methods gives the same values.
This can be interpreted that smaller VOIs more sensitive to errors of registration.
14
NEUROANATOMICAL CORRELATES OF POST-STROKE APHASIAS
ASSESSED BY RCBF BRAIN SPECT STUDIES
K. Jodzio1, D. Gąsecki2, D.A. Drumm3, P. Lass4, W. Nyka2
1Institute of Psychology, University of Gdańsk, Poland
2Department of Neurology, Medical University of Gdańsk, Poland
3Arizona State University, Scottsdale, USA, Department of Nuclear Medicine,
Medical University of Gdańsk, Poland
Background and aim: A large variety of acquired aphasic syndromes can be cor-
related to relatively specific brain lesions located at distinct sites in the left cerebral
hemisphere. The aim of the study was to determine neuroanatomical correlates of
aphasia following cerebrovascular accident.
Material and methods: The study involved 50 stroke patients with a single left-
-hemisphere lesion and residual mild to severe aphasia. Language, assessed by the
Boston Diagnostic Aphasia Examination (BDAE). rCBF SPECT scanning hads been
performed using 99mTc-HMPAO (Amersham, UK) i and a triple-head gammacamera
MS-3 (Siemens, Germany). We evaluated inter-hemispheric asymmetries using
asymmetry index (AI) and regional cerebral perfusion using cerebellar normalisa-
tion.
Results: In Broca’s aphasia were predominant changes in frontal lobe and — in
lesser degree in occipital lobe and striatum; in Wernicke’s aphasia mostly changes
in tempotal and occipital cortex were seen. In global aphasia rCBF SPECT scan-
ning showed largest perfusion deficits in perisylvian area and thalamus, also in
basal ganglia; however, the normal rCBF perfusion was seen only i occipital area.
Conclusions:
1. Results indicate a need for reevaluation of neuroanatomical correlates in apha-
sia, particularly elucidating the role of subcortical damage.
2. In particular types of aphasia we meet different locations of vascular damage.
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CHANGES IN THE CEREBRAL BLOOD FLOW IN DIABETES MELLITUS
L. Szabados1, I. Garai1, J. Varga1, L. Galuska1, M. Káplár2
University of Debrecen MHSC:
1Department of Nuclear Medicine
2Department of Metabolism
Background: in Type 2 diabetic (T2DM) patients, about 80% die of a macrovascu-
lar complication.
Aims: To measure the functional capacity of the brain arteries of T1DM and T2DM
patients, and to compare these results to various vascular haematological parame-
ters like CRP, fibrinogen level and myeloperoxidase activity.
Material and methods: 64 patients were involved (18 T1DM and 46 T2DM). Cere-
bral blood flow was examined by a two day protocol. Basal and subsequently Di-
amox-stimulated cerebral blood flow was measured on two different occasions.
Reserve capacity was calculated on the basis of the difference between stimulated
and basal blood flow. CRP and fibrinogen level along with the myeloperoxidase
activity of the neutrophil cells were also measured.
Results: Both basal and the Diamox stimulated cerebral blood flow was significan-
tly lower in T2DM, the reserve capacity, however, was the same in both groups
(T1DM: basal: 56.33 ± 8.87 ml/min, stimulated: 62.88 ± 10.41 ml/min; T2DM: bas-
al: 48.5 ±6.23 ml/min, stimulated: 52.76 ± 7.68 ml/min). Cerebral blood flow was
declining by age. After correcting for this age-dependent phenomenon cerebral
blood flow of T2DM patients still remained lower when compered to that of the
T1DM, although the difference was not significant. In T2DM significantly higher CRP
and fibrinogen level and increased myeloperoxidase activity was measured in com-
parison to the T1DM group.
Conclusion: Decreased cerebral blood flow of T2DM patients compared to T1DM
might represent a more pronounced vascular injury and significantly elevated CRP,
fibrinogen levels and myeloperoxidase activity seem to have a possible role in the
pathogenesis.
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CORRELATION OF DOPAMINE TRANSPORTER IMAGING
(TRODAT SPECT) AND PARKINSONIAN MOTOR HANDICAP
B. Kanyo1, G. Dibo2, P. Klivenyi3, M. Argyelan1, L. Vecsei3, L. Pávics1, 4
Departments of:
1Nuclear Medicine
2Municipal Outpatient Clinic Neurology, Szeged, Hungary
3Neurology, University of Szeged, Hungary
4International Medical Center, Szeged, Hungary
Background: The selective dopamine transporter ligand TRODAT SPECT is useful
in the diagnosis of Parkinson’s disease.
Aim of the study was the examination of the theoretical correlation between the
clinical motor symptoms and 99mTc-TRODAT uptake values.
Material and methods: The investigated population included 72 patients with Par-
kinson’s disease (30 men, 42 women; mean yr ± SD: 61.4 ± 11.5; disease duration
4.4 ± 4.7 yr; Hoehn-Yahr [H-Y]: 1.9 ± 0.7; UPDRS total [U]: 26.6 ± 17.6; UPDRS III
[III]: 16.1 ± 11.3). During semiquantitative assessment, as a specific binding region
the striatum (str), as a reference region the occipital cortex (occ) was marked. The
specific uptake of TRODAT was compared with the values of clinical rating scales.
For statistic linear regression was performed.
Results: The TRODAT uptake of the striatum correlated well with the values of Hoe-
hn-Yahr scale (str/occ ratio = 1.62–0.01*H-Y, p < 0.01), of UPDRS scale (str/occ
ratio = 1.53–0.003*U; p = 0.02) and of UPDRS III scale (str/occ ratio = 1.52–
–0.005*III, p < 0.01).
Conclusion: 99mTc-TRODAT SPECT not only useful in the diagnosis of Parkinson’s
disease but it’s also suitable to visualization of the severity of the disease.
18
DOPAMINE TRANSPORTER EXAMINATIONS IN MOVEMENT
DISORDERS: SUMMARY OF 4 YEARS (176 EXAMINATIONS)
B. Kanyo1, G. Dibo2, P. Klivenyi3, M. Argyelan1, L. Vecsei3, L. Pávics1, 4
Departments of:
1Nuclear Medicine
3Neurology, University of Szeged, Hungary
2Municipal Outpatient Clinic Neurology, Szeged, Hungary
4International Medical Center, Szeged, Hungary
Aim: We investigated the role of TRODAT SPECT in differential diagnosis in move-
ment disorders (i.e. Parkinson’s disease PD; Parkinsonian syndrome PS, essential
tremor ET).
Material and methods: During a 4-year-study 176 patients with parkinsonian fea-
tures were investigated with 99mTc-TRODAT SPECT. The different patient groups
(PD, PS, ET) and subgroups were compared with each other and with healthy vo-
lunteers. As a specific binging region the striatum, the caudate nucleus and puta-
men, as a reference region the occipital cortex was marked. For statistics linear
regression and ANOVA were performed.
Results: In PD patients a linear correlation was found between specific TRODAT
uptake values and motor handicap (p < 0.05), as well as -based on the different
uptake of striatum-99mTc-TRODAT SPECT differentiated subtypes of PD (p < 0.05).
During differential diagnostic study-based on the different putaminal involvement-
PD and PS groups separated each other (p < 0.05).
Conclusion: 99mTc-TRODAT SPECT investigation is useful by itself in the diagnosis
in patients with movement disorders.
17
ACETAZOLAMIDE-SENSITISED QUANTITATIVE BRAIN PERFUSION
SPECT IN DEPRESSION AND ALZHEIMER DISEASE
L. Galuska2, A. Égerházi1, L. Szabados2, I. Garai2, J. Varga2,
L.Z. Markó2, I. Degrell1
University of Debrecen:
1Department of Psychiatry
2Department of Nuclear Medicine
Aim: the risk of stroke and dementia is higher at patient suffering from depression.
Little is known about the possible pathophysiologic mechanism of it. So we com-
pared the basic quantitative global and regional blood flow, and blood flow cere-
brovascular reserve capacity (CVRC) at patients, suffering from depression (D) and
Alzheimer disease (AD)
Material and methods: 24 patients were investigated, with 48 examinations.
10 healthy controls, 5 with unipolar, 5 with bipolar D, and 4 with AD. First we have
made the 99mTcHMPAO dynamic, quantitative SPECT and later the Acetazola-
mide-sensitised quantitative brain perfusion SPECT done for CVRC calculation.  Data
acquisition and analysis: using the acquisited data of large field of view gamma
camera from aortic arch and brain hemispheric areas, time activity curves, and
reconstructed coronal SPECT slices of them in a cylinder surface-like model, was
used to measure the rest global hemispheric regional blood flow and later the CVRC
(The normal rest value: 53 ml/perc/100 g brain tissue is).
Results: in rest a serious global decrease in blood flow is observed at D and AD
patients. After Acetazolamide a smaller CVRC values have been observed at pa-
tients compared with normal. At pts with unipolar D the frontal region is relatively
better perfused, compared with bipolar D, in which the whole gray matter is serious-
ly underperfused. At AD pts the global perfusional loss of brain, and in parieto-
temporal areas a characteristic regional hypoperfusion is observed with low CVRC.
Conclusions: comparing with normals, there is a significant decrease of global rest
hemispherical blood perfusion at unipolar and bipolar D pts.The unipolar and bipo-
lar D may be separated, because in later case the frontal region is also involved is
global cerebral hypoperfusion. At unipolar D the higher blood flow values have been
measured in parieto-temporal regions than in AD. At bipolar D these values are near
to the values measured in AD. The CVRC is observable in all pts groups, but at the
lower level than at normals.
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PARATHYROID SCINTIGRAPHY AND ULTRASONOGRAPHY
IN PRIMARY HYPERPARATHYREOIDISM
T. Györke1, L. Duffek1, E. Palócz1, Z. Kopcsányi1, J. Horányi2, E. Makó1
1Semmelweis University, Dept. of Diagnostic Radiology and Oncotherapy
21st Department of Surgery, Budapest
Aim: According to recent surgical protocols primary localisation investigation is
required in primary hyperparathyroidism (PHP). We assessed retrospectively the
diagnostic efficacy of parathyroid scintigraphy (PTS) and ultrasonography (US) in
case of PHP.
Material and methods: The cause of  PHP could be proven by surgery and histo-
logy in 30 patients (age: 10–83 years; 25 females, 5 males) investigated during
2003 and 2004 at our institution. PTS was performed following the iv. application of 700
MBq Tc-99m labelled sestamibi and we obtained planar sequential images at least
2 hours long and SPECT investigation. In 11 cases we performed additional thy-
roid- and subtracted images following the iv. application of 100 MBq Tc-99m pertech-
netate. US investigations were performed by several investigators of 10 different
institutions. In 9 cases when the original US were negative we made control US
(CUS) in the knowledge of  PTS results.
Results: 35 lesions were resected (25 adenoma, 10 hyperplasia; 34 in the neck,
1 in mediastinum). The sensitivities of  PTS, US and CUS were 86, 13 and 89%,
respectively. PTS had 2 false positive findings while positive US findings were al-
ways correct.
Conclusions: In case of PHP the sensitivity of US was extremely low, significantly
lower than reported in the literature. Based on our CUS investigations this is not the
result of objective undetectability by ultrasound. PTS is an excellent method for
localising parathyroid tissue with increased functional activity. In case of positive
US finding the necessity of PTS is questionable.
23
THE CASE FOR TSH IN ELDERLY
M. Marik, A. Tombácz, A. Homonnai, G. Császy, T. Tóth, J. Nagy Kocsáné
Heves Megyei Önkormányzat Markhot Ferenc Kórház-R.I. Izotópdiagnosztikai
Osztály, Eger Approximately 17,000 super sensitive TSH tests are performed
annually in our laboratory.
Because of our aging population, 20% of the samples are from patients above 65
years. Our principal observations are the following:
1. 12% of the samples are in the normal range (0, 3–3,5 mU/ml) — 80% of these are
male patients.
2. 25% of the patients are hyperthyroid — without difference in gender.
3. The rest of the patients — approximately 60% — are hyperthyroid with a 95%
female dominance. Three possible reasons can explain the this difference:
a) due to the decreased metabolic rate, the elderly patient responds with increased
amount of TSH as a compensation mechanism, b) this is because the effect of the
high incidence of autoimmune thyroid diseases observed in our region,
c) alpha-chains reaching a high serum concentration in menopausal women are
associated with false-positive results.  In the first situation, feedback mechanism
can be suspected; for the examination of the second and the third reason, we per-
formed anti-TPO (RIA-CT) measurements to exclude autoimmune disease.  Sexual
hormones’ role as a principal cause of high concentration of TSH has been con-
firmed with FSH-LH (IRMA-CT) measurements.  Summarizing our results we can
conclude, that it would be useful to establish a higher cut off limit — at least 7.5 mU/ml
— when we define normal values for TSH.
21
ENDOCRINOLOGY
SOME AUTONOMOUSLY FUNCTIONING THYROID
NODULES RESIST THE SUBACUTE THYROIDITIS
I. Földes, A. Lévay
BM. Hospital, Department of Nuclear Medicine, Budapest
Aim: In subacute thyroiditis the iodine (technetium) uptake of the thyroid is very low,
the gland is hardly seen on the scan. In several patients “hot” spot was present on
the thyroid image obtained during the thyroiditis. To evaluate the frequency of this
finding we reviewed the scans made in the last 8 years.
Material and methods: Subacute thyroiditis was found in 102 patients, the diagno-
sis was based on clinical signs, elevated sedimentation rate and low technetium
uptake. Serum TSH, FT4 and FT3 were measured in all subjects, Tg, aTg and aTPO
were also assessed in special cases.
Results: On 18/102 scans registered during the subacute thyroiditis  a single “hot”
spot 4-10 mm in diameter was shown. The serum TSH measured at the time of
thyroid imaging was suppressed in 15/18 patients (< 0.1 mIU/L), the FT4 was in-
creased in 14/18 (24, 38–56.9 pmol/l). In 12 patients a control scan was performed
after recovering from the subacute thyroiditis. On this second scan the regions
formerly inflamed or suppressed showed normal uptake again, however the “hot”
spot remained visible further on.
Conclusion: The “hot” nodules found in the thyroid during subacute thyroiditis are
autonomous in function because they are able to accumulate technetium in spite of
suppressed serum TSH. It would appear that, the functional autonomy of the no-
dules and the ability to resist subacute thyroiditis have common pathogenesis.
24
INTRAOPERATIVE PARATHYROID ADENOMA
LOCALIZATION BY GAMMA PROBE
L. Duffek, J. Horányi, T. Györke
Semmelweis University, Faculty of Medicine Department of Diagnostic Radiology
and Oncotherapy, 1st Department of Surgery, Budapest
Aim: Unsuccessful cases of the conventional parathyroidectomy  are around 5% to
10%. Follow up procedure has been performed in order to investigate the improve-
ment of the efficiency of intraoperative radio-guided localization for parathyroid ad-
enomas by applying gamma probe.
Material and Methods: Intraoperative sestamibi scanning was carried out to local-
ize the adenoma by gamma probe in case of 115 parathyroiectomy patients with
primery hyperparathyroidism diagnose between February 2000 and December 2004.
700 MBq 99mTc-MIBI have been injected intravenously 1.5–2 hours before the nu-
clear-guided pararhyroid surgical procedure. The radio-pharmaceutical distribution
was measured by Europrobe with dedicated detector head for 99mTc. Counts/
/seconds (cps) were recorded on each particular points.
Results: The activity distribution was measured before the operation percutane-
ously on the neck. Only 37 cases (32.2 %)  were obtained relevant information about
the location  of parathyroid adenoma. In turn, the localization during the operation
directly at explored paratheroid regions improved to 75 cases (65.2%). Finally the
removed specimens were ex-vivo scanned, which provided the best results. Para-
thyroid adenoma was proved by 98% reproducibility in case of  resected parathy-
roid glands ex vivo tests.
Conclusion: The combination of intraoperative way with the intact PTH determina-
tion in parathyroidectomy may reduce the surgical time and risk as well as minimi-
zes the application of invasive surgical action.
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TC-99M-SESTAMIBI SCINTIGRAPY IN PATIENTS WITH
MULTIPLE MYELOMA
Z. Varga1, Z. Nagy1, K. Buga1, G. Mikala2, M. Petõ2, I. Szilvási1
National Medical Center:
1Department of Nuclear Medicine
2Department of Medicine, Budapest
Aim: To assess the diagnostic value of Tc-99m-sestamibi scintigraphy (MIBI) in
patients with multiple myeloma (MM) in differentiating between active stage of dis-
ease and remission to evaluate therapeutic response.
Material and methods: In a total 32 whole body scintigraphy after 15 minutes of i.v.
injection of 740 MBq MIBI in 24 patients (11 male, 13 female, median age: 62.7 years)
with MM were performed. 16 out of 32 cases had clinically active disease, 16 cases
were in remission. 8 patients had two MIBI scintigraphies: before and one month
after appropriate cytostatic treatment. Clinical activity was based on serum LDH,
electrophoresis and plasma cell content of the bone marrow.
Results: In clinically active MM 14/16 patients had abnormal MIBI scintigraphy:
diffuse intensive uptake with expanded bone marrow in the peripheral long bones.
Two out of 14 patients had extramedullary uptake as well. In 2 out of 16 patients with
remission increased MIBI uptake was found. Both patients were one month after
therapy. 14 patients had normal MIBI scintigraphy.
Conclusions: MIBI scintigraphy has high sensitivity and specificity (87.5%) in diffe-
rentiating between clinically active disease and remission in patients with MM but is
not reliable in early evaluation of therapeutic response.
27
ONCOLOGY
USE OF PREOPERATIVE CARCINOEMBRYONIC ANTIGEN
VALUES IN PROGNOSIS OF COLORECTAL CANCER
J. Lemberger1, S. Pinter², K. Novak3
General Hospital:
1Departments of Nuclear Medicine
²Department of Epidemiology, Subotica, Serbia and Montenegro
3Pathology and Public Health Institute
The aim of this work was to compare various CEA level and to investigate relation-
ship between marker values and tumor stage in estimation of disease prognosis.
Determination of CEA in blood were performed by IRMA in 146 patients before
radical tumor resection. Survival curves were computed using Kaplan-Meier meth-
od and difference between groups was tested using log-rank test. Predictive values
were estimated from survival curves. Based on achieved results and Dukes stage
patients were divided in groups with normal (< 10 ng/ml) and elevated (> 10 ng/ml)
level. The mean survival time was 40.7 ± 1.94 (SEM) months, 5-year survival pre-
diction rate was 47.4% ± 5.3%.No significant difference was found in survival re-
garding tumor localization (p = 0.8187). The mean survival of patients with normal
and elevated CEA values were 49.3 ± 2.46 months and 27.4 ± 2.44, respectively.
The difference was highly significant (p < 0.0001). Prognosis of Dukes A group is
more favourable than B and C (p = 0.0029). Furthermore, the difference between
survival curves in groups with normal and elevated CEA values of Dukes B and C
stage are significant (p = 0.0010 and p = 0.0371, respectively).The results sug-
gest, that prognosis of CEA negative and positive tumors is considerably different.
In conclusion, regardless of tumor stage, prognosis of colorectal tumors associat-
ed with elevated CEA is poorer than CEA negative tumors. The marker level is
a prognostic factor and could be taken into consideration in monitoring of patients
26
SOMATOSTATIN SCINTIGRAPHY (OCTREOSCAN)
IN CLINICAL PRACTICE
E. Schmidt1, Y. Al-Farhat², O. Ésik², K. Stefanits², E. Udvaros1, Z. Szabó1,
K. Zámbó1
1Department of Nuclear Medicine
²Department of Oncology Medical Faculty, University of Pécs
Aim: To establish the value of somatostatin scintigraphy in clinical practice.
Material and methods: The study included 29 patients: 25 patients was observed
with identified carcinoid or neuroendocrine tumor, for staging; 3 because of suspi-
cion of carcinoid; and 1 because of suspicion insulinoma. Anterior and posterior
abdominal and thoracic static imaging and SPECT study (Siemens, Multispect
2) were performed 24 and 48 hours after i.v. injection of 120 MBq 111-In-Octreoscan.
Results: Only 1 false negative somatostatin scintigraphy was found in the identified
carcinoid. In 8 cases the pathological accumulation were only on the SPECT study
visible, static scans were negative. In 15 cases we established multifocal accumu-
lation and the most part of spots were proved with other imaging techniques (UH,
CT and/or MR) too, but in 8 case only later. At 7 petients the other techniques could
not establish any abnormality yet, the  examinations are in process.
Conclusion: Somatostatin scintigraphy especially with SPECT images is a sensi-
tive and useful method in the staging and identifying carcinoid and neuroendocrine
tumors and in the planning of therapy.
25
OUR EXPERIENCES WITH SHORT, 5-DAY LITHIUM — ADJUVANT
ADMINISTRATION ALONG WITH RADIOIOD TREATMENT
OF HYPERTHYREODISM
Z. Kopcsányi, Z. Olbrich, H. Kamarás, M. Farkas
Péterfy S.U. Hospital, Budapest
Aim: To further increase the effectiveness of radioiod treatment with short Lithium
adjuvant therapy.
Material and methods: Lithium increases the intrathyreoidal iodine content. The
effective half-lifetime decreases the transient elevation of thyroid hormone concen-
tration after radioiod therapy. The disadvantage of this is toxicity. To avoid its toxic-
ity we used short 5-day Lithium therapy started right after to the radioiod administra-
tion with 16 patients where the I131 theraphy was formerly unsuccessful or where
we wanted to avoid the increase of FT4 after radioiod administration of the patients.
Results: We found that the favourable effect of Lithium was satisfactory when used
this way. Hyperthyreosis disappeared in 15 cases, only diminished in 1 case. There
were no side effects.
Conclusion: A 5-day Lithium therapy after radioiod administration may increase its
effectiveness without toxic side effects.
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TC99M-DEPREOTIDE SCINTIGRAPHY IN THE DIFFERENTIAL DIAGNOSIS
OF PULMONARY DISEASES
E. Takács1, Z. Varga, K. Buga, Z. Nagy, L. Tamási2, J. Kocsis1,
K. Tóth1, M. Zsiray M3, I. Szilvási
1National Medical Center, Kútvölgyi Clinical Center
2Department of Pulmonology of Semmelweis University
3National Institute of Pulmonology, Budapest
Aim: Of our study was to find a semiquantitative parameter on the Tc-99m-de-
preotide scintigraphic (TcD) images to differentiate between malignant and benign
depreotide accumulating pulmonary lesions.
Material and methods: in a total 40 focal pulmonary lesions of 25 patients
(14 male, 11 female, median age: 50 ± 12.6 years) were studied. 20 patients had
histologic diagnosis of pulmonary malignancies, 5 patients had benign inflammato-
ry lesions. Anterior and posterior images of the thorax were taken 2 and 4 hours
after i.v. injection of 740 MBq TcD. Counts/pixel values of the lesions (L), back-
ground (B) and contralateral tissue (C) were determined by ROI technique using
geometric mean calculation. L/B and L/C ratios were calculated on the 2-hours and
4-hours images as well. Statistical and ROC (area under the curve) analysis were
performed.
Results: L/B and L/C ratios on the 4-hours images were significantly higher than on
the 2-hours images for malignant and benign lesions as well. No significant differ-
ence of the L/C ratios was found between malignant and benign processes.
4-hours L/B ratio was significantly higher (1.62 ± 0.32) in malignant lesions than in
inflammatory diseases. This ratio had the highest discriminating value by ROC ana-
lysis as well.  In our patients L/B ratio over 1.7 suggests malignant disease.
Conclusion: calculation of the L/B ratio at 4 hours images of the TcD scintigraphy is
helpful in differentiating malignant and benign pulmonary diseases.
29
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DIFFICULTIES IN MANAGING OF DIFFERENTIATED THYROID
CANCER IN RELATION WITH THE CONSENSUS PROTOCOL
A. Konrády
Javorszky Ödön Hospital, VÁC
Diagnosis and treatment of differentiated thyroid cancer /DTC/ is well
documented.1o4 patients have been treated with radioiodine since l997 in 17o
occasions.This period was a continuous adjustment to the international protocol
the difficulties of which were considered in this report.
1. Incomplete thyroid resection:volume of remnant was larger than 2 gr in 52% and
131-I-uptake more than 10%:25,4%.
2. TSH-induction: today thyroxine withdrawal is the only option but recombinant
hTSH is generally recommended.We administered rhTSH only to 3 patients.
3. Serum-thyroglobulin (hTg) determinations with IRMA/ILMA are reliable methods
but one should often wait for the result for several days/weeks.
4. Whole Body Scan (WBS): thick crystals and high energy collimators are nece-
ssary and not always available.We had only two WBS-positive cases.
5. Ultrasound: an operator having day-to-day experience in evaluating thyroid can-
cer patients is needed.Solving of this problem is in progress.
6. PET: useful method for investigation of WBS-negative and hTg-positive patients
but not exclusively.
One should overcome the difficulties to go on.
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DISCOVER OF A GLUTEAL METASTASIS
OF A COLORECTAL ADENO-CARCINOMA BY BONE SCINTIGRAPHY
 — AN INTERESTING, RARE CASE
G. Pusztay1, Z. Nemessányi1, A. Kasza2, M. Kiss2, B. Szelei3, L. Kocsis4
1Department of Nuclear Medicine
2Department Radiologyof Semmelweis Hospital, Kiskunhalas
3Department of Radiology
4Department Pathology of County Hospital, Kecskemét
Background: It is well known that distant metastasis of colorectal carcinoma pri-
marily occurs in the liver and lung. The sceletal muscle is undoubtedly the most
unusual site of distant metastasis from any cancer, despite the fact that sceletal
muscle comprises nearly 50% of the total body mass. Metastases to sceletal mu-
scle from colorectal carcinomas are extremly rare, to our knowledge, only 15 cases
have been reported in the world literature.
Case report: A 63-year-old women was examinated by bone scintigraphy 4 years
after surgical treatment of colorectal carcinoma. Bone scintigraphy shows an ex-
traosseal MDP-accumulation of the left gluteal region.
Based on this aspecific finding advised CT-scan and fine-needle biopsy reveal
a metastasis of the colorectal adenocarcinoma.
Discussion: The results of additional examinations, which was made by the basis
of incidental finding of bone scintigraphy, indicated a complete change in the plan
of therapy.
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COMPARATIVE EVALUATION OF TC-99M-SESTAMIBI
AND TC-99m-ANTIGRANULOCYTE-ANTIBODY
IMMUNOSCINTIGRAPHY IN MULTIPLE MYELOMA
Z. Varga1, Z. Nagy1, K. Buga1, G. Mikala2, M. Petõ2, I. Szilvási1
National Medical Center:
1Department of Nuclear Medicine
2Department of Medicine, Budapest
Aim: To compare diagnostic value of the Tc-99m-sestamibi (MIBI) and the Tc-99m-
-antigranulocyte antibody bone marrow (BM) scintigraphy in patients with multiple
myeloma (MM). Correlation between scintigraphic findings and clinical activity of
the disease was studied.
Material and methods: 16 patients (9 male, 7 female, median age: 60.5 years)
were enrolled in the study. Whole-body scintigraphy 15 minutes after i.v. injection of
740 MBq MIBI and — within one week — 4 hours after i.v. injection of 600 MBq Tc-
-99m-antigranulocyte monoclonal antibody (BM). 7 patients had clinically active
disease, 7 patients were in remission. Clinical activity was determined by serum
LDH, electrophoresis and plasma cell content of the bone marrow.
Results: Diffuse intensive activity uptake with peripheral extension of the bone mar-
row was found on MIBI scintigraphy in each of the 7 clinically active patients. On BM
scintigraphy 5 patients had focal bone marrow defects, 2 of them had bone marrow
expansion as well. 2 patients had normal scintigram. In 9 patients with remission
MIBI was normal in 7 cases, 2 patients had intensive bone marrow uptake with
expansion. BM Scintigraphy was normal only in 2 cases. 6 patiens had bone mar-
row expansion, 3 patients had focal bone marrow defects.
Conclusions: MIBI is sensitive and specific, BM scintigraphy is sensitive but not
specific to detect clinical activity of MM.
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RADIOGIUDED SENTINEL LYMPH NODE BIOPSY AND SIMULTANEOUS
OCCULT LESION LOCALIZATION IN BREAST CANCER PATIENTS
M. Lázár1, 2, G. Lázár3, Z. Besenyi1, 2, T. Séra1, 2, M. Papós1, 2, K. Szentpáli3,
A. Paszt3, K. Ormándi1, 4, R. Hajnal-Papp5, E. Szabó1, 4, T. Mikó5, J. Julesz6,
L. Kardos1, A. Palkó1, 4, L. Pávics1, 2
1IMC Szeged,
2Department of Nuclear Medicine
3Department of Surgery
4Department of Radiology
5Department of Pathology
6Department of Endocrinology, University of Szeged, Szeged, Hungary
Aim: To investigate the usefulness of radioguided sentinel lymph node (SN) biopsy
in breast cancer patients and the simultaneously performed radioguided occult le-
sion localization (ROLL) in patients with non-palpable breast tumour.
Material and methods: 150 non-palpable tumour (128 US, 22 X-ray guided) and
simultaneous SN localization were performed in 147 patients administering the ra-
diopharmaceutical (99mTc-Senti-Scint) intratumourally (group A). SN localization
and biopsy were performed in 67 patients with palpable breast tumour (group B)
applying peritumoural administration. Afterwards all patients underwent open sur-
gical tumour excision and axillary SN biopsy with the use of a gamma probe and
Patentblau staining. In most of the cases radiographic specimen control and later
histopathological analysis were made is every case.
Results: According to the radiographic specimen control all of the earlier visualised
tumours were removed. In group “A” all the histopathologically detectable tumour
tissue was successfully removed in 130 (87%) of the cases (9 reexcision and 11
mastectomy were necessary). The tumours were benign in 28 cases. Sns were
positive in 37 cases and in 7 cases the complementary axillary dissection showed
further lymph node positivity. In 12 cases (8%) the SN detection was not successful.
In group “B” posterior mastectomy was necessary in 8 cases. In 19 cases histo-
pathologically positive SN(s) and out of them further lymph node positivity was found
in the axillary block in 9 cases. Two tumours were benign. SN localization was not
successful in 3 cases (4%).
Conclusion: The method we used is suitable for the detection of SN (both by peri-
tumoural and by intratumoural radiocolloid administration) and for the simultaneous
localization of non-palpable breast tumours.
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PROGNOSTIC VALUE OF SENTINEL NODE TUMOUR INFILTRATION
IN MELANOMA MALIGNUM — A THREE-YEARS FOLLOW-UP
M. Papós1, 2, J. Oláh3, M. Lázár1, 2, J. Varga3, K. Kapitány3, I. Korom3, E. Varga3,
A. Dobozy3, L. Pávics1, 2
1IMC Szeged
2Departments of Nuclear Medicine
3Dermatology and Allergology, University of Szeged, Szeged
Aim: The prognostic value of malignant involvement of  sentinel node (SN) was
analysed in melanoma malignum (MM) patients.
Material and methods: SN localisation was performed in 110 MM patients with
99mTc-nanocolloids (SENTI-SCINT) preoperatively by gamma-camera technique,
and intaoperatively using gamma-probe method. The prognostic role of MM in-
volvement of the SN was analysed by comparison with the 3-years MM associated
mortality.
Results: Intaoperatively SN was found in all patients; 137 SN in concerning to 122
regions. In 74 cases (67%) SN has been proven to be MM free. In 36 patients (33%)
SN was MM positive. In 29 of these patients block-dissection was performed. In 16
cases (55%), the block lymph nodes were MM free. In 13 patients (45%) block
nodes showed MM involvement.
In SN negative patients the 3-years MM associated mortality was 7% (5/74), and in
MM positive SN cases 19% (7/36). The MM involvement of block lymph nodes has
not been proven to be a bad prognostic sign: the MM associated mortality in block
negative cases was 31% (8/16), and in block positive patients 15% (2/13).
Conclusions: In MM patients the malignant involvement of SN is a bad prognostic
sign in concerning to the 3-years mortality. In this group of  patients, the MM in-
volvement of block lymph nodes was not found to be a bad prognostic marker.
AXILLARY RECURRENCE IN BREAST CANCER FOLLOWING  SELECTIVE
AXILLARY LYMPH NODE DISSECTION BASED ON SENTINEL
NODE BIOPSY
M. Sinkó1, M. Rajtár1, G. Cserni2, G. Boross3, W.E. Tekle1, É. Ambrózay4
Bács-Kiskun County Hospital Kecskemét:
1Department of Nuclear Medicine
2Department of Pathology
3Department of Surgery
4Department of Radiology
Aim: 1. To evaluate the rate of axillary recurrence in patients with clinically T1-2N0
breast cancer omitted axillary lymph node dissection (ALND) based on negative
result of sentinel node biopsy (SNB).
2. A retrospective judgement of our SNB method.
Material and methods: Between October 2000 and June 2005 selective ALND
was performed in 329 breast cancer patients, i.e. ALND was omitted in patients with
negative sentinel node(s). Combined labelling method was used (Tc99m labelled
nanocolloid was injected peritumorally on the day before the operation + blue dye
was injected peritumorally just before the operation). Hot and blue lymph node(s)
only were declared as sentinel node(s) during surgery. ALND was omitted in 192
patients on the basis of negative result of intraoperative imprint cytology of sentinel
node(s). Clinical and axillary US follow-up was carried out six-monthly in 176/192
patients. The mean of follow-up time was 22.2 months (range 6–48 months).
Results: Suspicion of axillary recurrence was raised in 3/176 patients  (US 3, palpa-
tion 2 patients), but none of them proved to have malignancy by histology In conse-
quence, during around 2 years follow-up in none of 176 patients omitted ALND
(based on negative result of sentinel node biopsy) developed axillary recurrence.
Conclusions: Our results suggest that 1. using strict patient enrollment 2. using
combined radiocolloid and blue dye labelling technique 3. with the collaboration of
a properly trained team (nuclear medicine, surgery, pathology) selective ALND based
on SNB is a safe and appropriate method in early breast cancer.
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DIAGNOSTIC VALUE OF 99mTC-NEOSPECT EXAMINATION
IN DIFFERENT PULMONARY DISEASES
E. Udvaros1, K. Zámbó1, V. Sárosi2, E. Schmidt1, Z. Szabó1, Z. Balikó2
1University of Pécs, Medical Faculty, Department of Nuclear Medicine
2Baranya County Hospital, Department of Pulmonology
Aim: The 99mTc-Neospect binding to the somatostatin receptors has a crucial role
in the differential diagnosis of the solitary pulmonary nodules. The aim of this study
was the establishment of the diagnostic value of the method.
Material and methods: 27 patient (10 men, 17 women) were examined. Whole-
body scan and SPECT examination about the chest were performed in every pa-
tients by Multispect II double-head Siemens equipment. At the patients preliminary
chest x-ray, CT, MRI examinations were made and in 13 patients PET examination
was performed, too. The histological diagnoses were adenocarcinoma in 9, bron-
choalveolar carcinoma in 1, planocellular carcinoma in 3, carcinoid in 6, neuroen-
docrine tumor in 1, sarcoidosis in 2 cases and 5 benign or non-verificated cases
were found.
Results: On the base of the histological diagnosis and the operation the results of
the Neospect examination of 20 patients were true-positive. Negative results were
found in 4 patients, one of them a positive PET examination was performed, it was
adenocarcinoma. PET study was made in 12 from the 23 positive-results patients,
the results were concordant in 10 cases. In 2 patients negative PET results were
found, but one of them had recidive carcinoid, the other had bronchoalveolar carci-
noma. False-positive Neospect eaxmination were obtained in 2 cases of sarcoido-
sis. Both the Neospect and the PET examination was false-positive in 1 patient with
a scar in the chest. On the base of our results the sensitivity was 95% and the
positive predictive value was 86%. The specificity was lower, only 50%, the negative
predictive value was 75%. (few negative cases were eaxmined.)
Conclusion: The 99mTc-Neospect eaxmination is a very suitable and sensitive
method in the diagnosis of the histologically different pulmonary diseses and also
plays an important role in the planning of the therapy. But the comparison with the
other imaging studies is very important because of the low specificity.
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DEVELOPMENT OF 11C ISOTOPE LABELLED A2A ADENOSINE
RECEPTOR LIGAND FOR PET STUDY
E. Németh1, G. Horváth1, J.P. Szabó2, P. Mikecz1, J.A. Szentmiklósi3,
L. Trón1, T. Márián1
1PET Center
2PET Research Group of Hungarian Academy of Science
 3Department of Farmacology University of Debrecen
The purpose of the work was to synthesized 11C isotope labeled selective adenos-
ine A2A receptor ligand (E)-8-(3-iodostyryl)-1,3,7-trimethylxantine (ISC), with high
specific activity.We prepared the inactive ISC from 3-amino-cinnamic acid, the in-
termediate product was 3-iodo-cinnamic acid and (E)-8-(3- iodostyryl)-1,3-dimet-
hylxantine (ISX). We identified the final and intermediate product with thin layer chro-
matography and melting point measurement. We made HPLC and NMR analysis of
precursor of ISC (ISX) and ISC. We used [11C]CH3I as labeling agent reacted with
(E)-8-(3-iodostyryl)-1,3-dimethylxantine than we obtained [11C]ISC. The product was
separated from the reaction mixture with semipreparative HPLC procedure. The
final product was analyzed with analytical HPLC. Using this procedure the adeno-
sine receptor ligand were synthesized with radiochemical purity of 98% and specific
activity of 250–350 GBq/µmol (n = 10). Analyzing the final product in the water
solution we detected E-Z isomerism. Previous experiments showed 16% of E-iso-
mer transformation to Z-isomer on exposure for 2 hours to 20 W source of light. The
A2A specificity and selectivity was proven by pharmacological.
This work was supported by OTKA T-038270 grant.
DIAGNOSTIC ADVANTAGES OF PET/CT COMPARED
TO PET IN ONCOLOGIC PATIENTS
I. Szilvási1, Z. Nagy1, P. Lind2
National Medical Center:
1Department of Nuclear Medicine, Budapest LKH Klagenfurt
2Department of Nuclear Medicine and Endocrinology
Aim: To evaluate diagnostic advantages of PET/CT compared to PET in 100 onco-
logic patients with FDG-PET/CT examination.
Material and methods: PET/CT examinations of 100 consecutive patients with var-
ious oncological diseases were studied. FDG PET was indicated using 1a and 1b
categories of the German Consensus Conference. 370–700 MBq F-18-FDG was
injected. PET/CT examination was performed using a state-of-art machine (two-
-slices spiral CT, dedicated LSO-PET, 3D aquisition). First the attenuation-corrected
PET images were evaluated without CT findings. Next day integrated evaluation of
the FDG distribution was performed using diagnostic CT data. Comparison of the
two evaluations was made on the transversal slices by lesion-to-lesion. Number of
false positive and false negative interpretation of FDG accumulation was deter-
mined in all regions. Possibility of accurate anatomical localization of FDG accumu-
lating lesions was studied.
Results: False positive interpretation of FDG accumulating foci was significantly
decreased in the neck region, in the location of gastrointestinal sphincters, in the
bowel and urinary bladder regions. Metal in the dental region frequently results in
false positive lesions on the attenuation-corrected PET images of the neck.  Accu-
rate anatomical localization of cervical, mediastinal and abdominal lymph nodes
were possible by using integrated evaluation only. Localization of hepatic lesions
were accurate without CT in majority of the cases.
Conclusions: Integrated evaluation of metabolic and anatomic imaging increases
diagnostic accuracy of FDG-PET in oncological patients by decreasing false posi-
tive interpretation of FDG distribution and by accurate localization of abnormal lymph
nodes.
DIAGNOSTIC ADVANTAGES OF PET/CT COMPARED
TO PET IN ONCOLOGIC PATIENTS
I. Szilvási, Z. Nagy
National Medical Center, Department of Nuclear Medicine, Budapest
Aim: To evaluate diagnostic advantages of integrated morphometabolic interpreta-
tion of PET/CT compared to PET in the first 100 oncologic FDG-PET/CT examina-
tions.
Material and methods: PET/CT examinations of 100 consecutive patients with var-
ious oncological diseases were studied. FDG PET was indicated using 1a and 1b
categories of the German Consensus Conference. 370–700 MBq F-18-FDG were
injected. Simultaneous PET and diagnostic CT examinations were performed using
a PET/CT with two-slices CT and LSO-PET in 3D aquisition mode. On the first day
attenuation-corrected and uncorrected PET images were evaluated without the CT
findings by two NM physicians (I.Sz., Z.N.) unexperienced in reading PET/CT. Next
day FDG distribution was evaluated by using diagnostic CT data too. Comparison
of the two evaluations was made by lesions-to-lesions. Number of false positive
and negative interpretations of FDG accumulation were determined in all regions.
Reliability of accurate anatomical localization of FDG accumulating lesions was stu-
died.
Results: False positive interpretation of FDG accumulating foci was significantly
decreased by simultaneous evaluation of CT in the regions of neck, gastrointestinal
sphincters, and in the bowel and urinary bladder regions. Artifacts were frequently
(79/100) seen as false positive lesions on the attenuation-corrected PET images of
the oral region. Accurate anatomical localization of cervical, mediastinal and ab-
dominal lymph nodes were significantly improved by using integrated evaluation
(in 86%, 72% and 76% respectively). Localization of hepatic and splenic lesions
were accurate without CT in majority of the cases.
Conclusions: Integrated evaluation of metabolic and anatomic imaging increases
diagnostic accuracy of FDG-PET in oncological patients by decreasing false posi-
tive interpretation of FDG distribution and by accurate localization of abnormal lymph
nodes.
This study was supported by IAEA (C6/HUN/03008), and kindly supervised by
P. Lind, LKH Klagenfurt, Department of Nuclear Medicine and Endocrinology.
THE DIAGNOSTICAL AND DIFFERENTIALDIAGNOSTICAL
VALUE OF F18- FDG-PET IN VACULITIS
A. Szikszai, S. Rozeboom, J. Marienhagen, C. Eilles
Klinikum der Universität Regensburg, Abteilung für Nuklearmedizin, Regensburg,
Germany
Aim:The diagnostical and differentialdiagnostical value of FDG-PET in various types
of vaculitis was examined.
Material and methods: We examined 25 patients with verified vasculitis using the
ARA-Criteria wit F18-FDG-PET. In 14 patients brain and whole-body scans were
performed, and in 11 patients only a whole-body scan was aquired. The patients
were retrospectively classified as vasculitis of the large vessels (13 cases) and vas-
culitis of the middle- and small vessels (12 cases).
Results:All patients with vasculitis of the large vessels (n = 13) showed at least in
one location of the large vessels increased FDG Uptake, but only two patients of
7 (29%) showed typical changes of vasculitis in the brain. Of the 12 patients with
vasculitis of the middle- and small vessels 2 showed (17%) pathological changes in
large vessel locations and 6 from 7 (86%) showed typical changes of vasculitis in
the brain.
Conclusion: The brain and the whole-body F18-FDG examination benefitial in diag-
nosis and differentialdiagnosis of various types of vaculitis.
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EVALUATION OF A PET-ISOTOPE LABELLED A2A ADENOSINE
RECEPTOR LIGAND
J. P-Szabó1, E. Németh2, J.A. Szentmiklósi3, Z. Bagoly4, L. Balkay2,
Z. Krasznai5, L. Trón1, 2, T. Márián2
1PET Study Group of Hungarian Academy of Sciences
2PET Center
3Department of Pharmacology
4Clinical Research Center
5Department of Biophysics and Cell Biology, University of Debrecen
We report on the biological evaluation of an A2A specific adenosine receptor anta-
gonist developed in our laboratory.
The (E)-8-(3-jódsztiril)-1,3,7-trimetilxantin (ISC) receptor ligand was labeled with 11C
isotope. Results of contractility and relaxation studies also supported the high spec-
ificity and selectivity of this A2A receptor ligand. The A2A/A2B and A2A/A1 selectivity was
found to be 15 and > 200, respectively. Specific binding of [11C]ISC to adenosine
receptors was investigated on DDT1 MF-2 cells and competition between labeled
and unlabelled ISC was documented. [11C]ISC-receptor binding was effectively
blocked by CSC (an A2A antagonist) while DCPCX (A1-type antagonist) did not
affect the ISC-receptor interaction. Tissue accumulation of [11C]ISC was followed ex
vivo in Balb C mice. Remarkably high accumulation was found in the intestine, sto-
mach, heart and kidneys. Dynamic PET scans were carried out on rabbits to elabo-
rate detailed accumulation kinetics of [C11]ISC in heart, lung, liver, kidney, spleen
and brain. The labeled ligand can serve as a useful tool in in vivo studies of adeno-
sine receptor regulation.
This work was supported by the OTKA T-038270 grant.
EFFECTS OF NA+/CA2+ EXCHANGE ON THE ACCUMULATION
OF TUMORDIAGNOSTIC  PET TRACERS IN CANCER CELLS
T. Márián1, J.P. Szabó2, E. Németh1, L. Trón1, 2, E. Friedlander3,  O. Ésik4,
Z. Krasznai3
1PET Center
2PET Study Group of Hungarian Academy of Sciences
3Department of Biophysics and Cell Biology
4University of Debrecen, Department of Oncology, University of Pécs
The Na+/Ca2+ exchanger (NCX) plays crucial role in the calcium homeostasis of
cells. In the present paper we describe the effects of NCX blockers on the 18FDG
and 11C-choline accumulation in different cancer cells. We demonstrated that the
NCX is expressed at a remarkable level in the cytoplasmic membrane of the exam-
ined cells. Incubation of the cells with NCX blockers (bepridil, KB-R7943, 3’,4’-dichlo-
robenzamil hydrochloride) resulted in an increase of the intracellular Ca2+ with
a simultaneous decrease of the intracellular Na+ concentration. In addition the treat-
ment with the blockers increased the energy consumption of the tumour cells by
30–80%. The increased energy demand is explained by the higher activity of the
sarco-endoplasmic reticulum Ca2+-ATPase.  Preincubation in sodium free environ-
ment or thapsigargin (an effective blocker of the Ca2+-ATPase) pretreatment abo-
lished the increased FDG accumulation of the cells. The applied NCX blockers de-
creased the 11C-choline accumulation by 40–80% relative to the control. Our results
indicate that NCX medication protocols have to be taken also into account while
interpreting tumour tracer accumulations.
This work was supported by the OTKA T-038270 grant.
DEVELOPMENT OF A CALIBRATION SOFTWARE TO STUDY
SMALL ANIMAL -PET DETECTOR MODULES
S. Kis1, L. Balkay1, M. Emri1, E. Németh1, J. Molnár2 , I. Bagaméry3, L. Trón1, 4
1PET Center, University of Debrecen Medical and Health Science Center
2Institute of Nuclear Research, of the Hungarian Academy of Sciences
3Mediso Ltd.
4PET Research Group of Hungarian Academy of Sciences
Background: We have developed a PET camera for small animal studies at the
PET Center of the University of Debrecen. We apply LSO scintillation crystals in the
detectors that are arranged in 8x8 matrices in each module, and use a position
sensitive photomultiplier tube with an appropriate optical connection.
The corner signals of PMT contain the crystal position and energy data of the events.
We constructed four such detector-blocks and rotating them we will achieve tomo-
graphical PET projection.
Material and methods: The aim of our work is to develop special software in order
to determine the detector parameters (such as energy discrimination levels, pin-
crystal positions, etc.). The software will be capable of visualizing the calculated
detector properties and restore them for a data acquisition software unit. The deve-
lopment has been assisted using a MATLAB software package because it contains
a lot of useful predefined methods, such as segmentation, high-level optimization
algorithms, 2D and 3D visualization tools needed to achieve our goals.
Results: During data processing, the deviation of parameters of individual crystal
elements turned out to be considerably high, so it was essential to perform the
appropriate normalization prior to starting small animal studies.
THE ROLE OF FDG PET IN ACCURATE DIAGNOSIS OF VASCULAR
GRAFT INFECTION
B. Kálvin1, C. Tóth2, I. Garai3, S. Olvasztó2, P. Mikecz1, L. Papp2, L. Trón1
1PET Center, Medical and Health Science Center, University of Debrecen
2Vascular Surgical Unit, Medical and Health Science Center, University of
Debrecen
3Department of Nuclear Medicine, Medical and Health Science Center,
University of Debrecen
 Background: The diagnosis of vascular graft infection relies on a combination of
clinical symptoms and imaging findings. Labeled leukocyte scan are the most used
diagnostic tool. The usefulness of FDG PET is not yet evaluated. We report two
cases of vascular graft suppuration where the patients were examined by leukocyte
scan and FDG PET.
Material and methods: The first patient underwent a femoro-popliteal bypass in
1997 (Case No. 1). By the other patient aorto-bifemoral bypass had been carried
out previously (Case No. 2). 99m-technetium labeled leukocyte scintigraphy was
performed. Planar images were obtained. PET images were obtained 40 min after
the intravenous administration of 0.15 mCi × kg-1 of FDG. There was no correction
to tissue attenuation.
Results: The grafts were found to be infected in both cases during surgical revision.
PET imaging gave the correct diagnosis in both cases as it demonstrated abnormal
FDG uptake in areas corresponding with the vascular graft. In contrast with PET,
white blood cell scan gave false negative result in Case No. 2. where retroperitoneal
graft infection was suspected. The leukocyte scan demonstrated abnormal uptake
in the left thigh corresponding with the graft in Case No. 1.
Conclusion: There are only few articles that describe the use of FDG PET in dia-
gnosis of vascular graft infection. We recognize that FDG PET was 100% accurate
in diagnosing both the fact of the graft infection and its extent. Further evaluation in
a large group of patients is indicated to assess whether FDG PET could become
the imaging of choice when graft infection is suspected and other means of ima-
ging result in ambiguous diagnosis.
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NEURAL CORRELATES OF SPATIAL NAVIGATION:
A VIRTUAL REALITY PET STUDY
C. Borbély1, Z. Barta2, P. Halász1, T. Sipos2, L. Trón2
1National Institute of Psychiatry and Neurology, Budapest
2PET Center, University of Debrecen, Debrecen
The neural basis of navigation by humans was investigated with functional neuroim-
aging of brain activity during navigation in complex virtual reality environment. We
used positron emission tomography (PET) to scan six healthy male subjects while
they navigated to locations in a familiar virtual reality town build up during
a period of exploration immediately before scanning. Navigation was compared
with a task in which subjects moved trough another town following a trail of arrows,
thus not need to refer to an internal topographical representation of the town. The
results revealed significant activation of left superior occipital lobe (Br. 19), right
parietal lobe, precuneus (Br. 39), right temporal lobe, fusiform gyrus (Br. 37, 20),
bilateral parahippocampal gyrus (Br. 19), bilateral posterior cyngulum (Br. 23, 30)
and left middle frontal gyrus (Br. 6, 8) in navigation task in comparation with the
baseline. The results are consistent with previous neuropsychological and functio-
nal neuroimaging findings of the involvement of the temporal (mediotemporal) and
parietal regions, especially of the right side, in topographical memory.
LOCALIZATION OF LANGUAGE-RELATED BRAIN AREAS WITH
15O-LABELED WATER PET IN PATIENTS WITH UNILATERAL TEMPORAL
LOBE EPILEPSY
Z. Barta1, C. Borbély2, Z. Clemens2, P. Halász2, I. Kertész1, G. Horváth1, L. Trón1
1PET Center, University of Debrecen, Debrecen
2National Institute of Psychiatry and Neurology, Budapest
Since introduction of 15O-labeled water PET as a method for measuring regional
blood flow changes under different activation tasks, many functional brain mapping
experiments have been designed to investigate human language functions. It was
shown that tasks involving semantic analysis were best suited to detecting left-right
differences in the activation pattern. We focused on the question of whether PET
during speech activation is an appropriate method for noninvasive determination of
language-related brain areas in epileptic patients with unilateral temporal lobe pa-
thology. Twelve right-handed TLE patients were examined (7 with pathology on the
right side, 5 on the left) in a verb generation task paradigm (finding a semantically
matching verb for each noun read aloud) compared with the baseline resting con-
dition (dark room, eyes closed). The results shown that in the left sided group highly
significant activated regions were the superior temporal gyrus bilaterally (Br. 41, 22)
left middle and inferior frontal gyrus (Br.6, 46) and  right cerebellum. In the right
group significant activations were the left superior temporal gyrus (Br. 22), left infe-
rior frontal gyrus (Br 45), left middle and medial frontal gyrus (Br. 6,8) and cerebe-
llum bilaterally. In a comparison between two groups we found  significant  activa-
tions of right superior temporal gyrus (Br. 22) in left group and right medial frontal
gyrus in patients with pathology in the right side. In conclusion, the presence of
structural pathology in the left (verbally dominant) temporal lobe caused a more
bilaterally distribution of language processing and the measurement of CBF chan-
ges during verb generation task seems to be useful method in identification of lan-
guage-related areas in epileptic patients with unilateral temporal pathology.
MAPPING OF GLUCOSE METABOLISM IN PATIENTS WITH
HUNTINGTON’S DISEASE
S. Szakáll1, E. Emri1, L. Balkay1, E. Németh1, F. Mechler2, L. Trón1
1PET Center, Medical and Health Science Center, University of Debrecen
Debrecen
2Department of Neurology, Medical and Health Science Center, University
of Debrecen, Debrecen
Background: Huntington’s disease (HD) is an autosomal dominantly inherited neu-
rodegenerative disorder characterized by worsening abnormalities of movement
and cognition. Genetically screened gene mutation carriers and symptomatic pa-
tients were examined regarding the affection of the basal ganglia, and the possible
metabolic changes of the cortex.
Material and methods: 19 patients (13 presymptomatic gene carrier and 6 symp-
tomatic) and 6 healthy volunteers were included in the study. All patients had HD in
familial history and all had CAG repeat above the normal limit (> 37). The presymp-
tomatic group was devided into 2 subgroups based on the CAG repeat number.
Dynamic brain FDG-PET investigations were performed in all subjects. A 3-com-
partmental model was applied for the kinetic analysis. All individual PET images
were transformed into the MNI space. SPM analyses were carried out to ascertain
statistical differences in the striatal and cortical metabolism between patient groups
and healthy subjects. The regional rate of glucose consumption was also deter-
mined in all cases with defining different VOIs on the standardized MRI images. The
obtained values were ratio-normalized (nGMR) to unit global metabolic rate. The
results were compared to those of the control group.
Results: Severe bilateral hypometabolism was detected in the caudate nuclei and
the striatal region in the 6 symptomatic patients. 10 presymptomatic patients had
different degree of reduced metabolism of the basal ganglia. The remaining 3 with
CAG repeat less than 40 had normal scans. Statistical differences were found with
SPM analysis between the patient groups and healthy subjects in the severity of the
striatal hypometabolism. Compared to the control group, reduced metabolism was
observed in the medial frontal gyrus in the symptomatic patients. On the other hand,
there was non-significant hypermetabolism in the right superior frontal and left me-
dial and middle frontal gyrus in this group. In addition, metabolism was elevated in
the left inferior and superior temporal and in the left medial frontal gyrus in the pre-
symptomatic patients with intermediately reduced glucose uptake.
LYMPHOSCINTIGRAPHY IN CERVICAL CANCER PATIENTS;
DEEP VS. SUB-EPITHELIAL INJECTION TECHNIQUE
D. Wydra1, S. Sawicki1, J. Emerich1, T. Bandurski2, P. Lass2
1Department of Gynaecology
2Department of Nuclear Medicine, Medical University, Gdańsk, Poland
Background and aim: Regional lymph node surgical management is an integral
part of cervical cancer therapy. In gynaecological oncology, recent studies have
confirmed the utility of the sentinel node concept in vulvar and cervical cancer. The
method of marker’s administration is considered to play an important role in senti-
nel node detection. The aim of the study was to assess the sensitivity of sentinel
node detection by the use of pre- and intra-operative radiodetection versus blue-
dye method in patients with cervical cancer, as well as the influence of sub-epithe-
lial versus deep way of tracer administration.
Material and methods: We studied 60 patients with cervical cancer (stage IB-IIA)
using a blue dye injection technique and radionuclide studies with a pre-operative
scintigraphy utilising a nanocolloid tracer/dual-head gammacamera and intra-op-
erative gamma-probe technique during radical abdominal hysterectomy. In 30 ran-
domly chosen patients the tracer was administered using deep (0.5–1.0 cm) injec-
tion technique; in 30 by sub-epithelial injection.
Results: All sentinel nodes visible in pre-operative scanning were also detected by
intra-operative gamma probe. After deep injection sentinel nodes were showed in
27 patients (90%) on both sides, in 3 pts. on one side; only 40% of sentinel nodes
were detected using blue dye technique. Following sub-epithelial injection of radio-
isotope sentinel nodes were found in all 30 patients (100%), after blue dye injection
in 28 patients (93%).
Conclusions: Radionuclide sentinel node detection seems to be slightly superior
as compared to blue dye technique. Sub-epithelial administration provides better
sensitivity of sentinel node detection, probably due to differences in lymphatic ves-
sels architecture.
SENTINEL NODE
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CLINICAL VALUE OF LYMPHOSCINTIGRAPHY IN CHILDREN
WITH LYMPHEDEMA OF THE LOWER LIMB
K. Buga1, Z. Nagy1, Z. Varga1, G. Tasnádi2, I. Szilvási1
1National Medical Center, Department of Nuclear Medicine
2Heim Pál Hospital, Department of Surgery, Budapest
Aim: To evaluate clinical relevance of lymphoscintigraphy (LS) in the diagnosis and
postoperative follow-up of pediatric patients with lymphedema (LE) of the lower
limbs.
Material and methods: 47 patients (21 boys and 26 girls) with long-standing ede-
ma of non-venous origin of the lower limbs were studied, median age of 9.6 years
(2–26). 43 patients had edema on one limb, 4 patients on both limbs. 5 patients
underwent microsurgery of the lymphatic vessels before the study. 20–40 MBq Tc-
99m-nanocolloids were injected subcutaneously on both legs. A 30 minutes dy-
namic study and whole-body scintigraphy at 1, 4 and 24 hours were performed.
Dynamics of lymph flow, visualization of the lymphatic vessels, the lymph nodes
and the liver were evaluated by a score-system. Local retention of radiopharmaceu-
tical was also measured expressed in per cent of the injected activity.
Results: In 9 patients LE was excluded by normal LS. Hypoplasia of the lymphatic
system was diagnosed in 26 patients  (in 4 children on both limbs), 12 patients had
lymphatic aplasia of one lower limb. Significant negative correlation was found be-
tween severity of the LE and score values of flow, visualization of lymphatic vessels
and nodes and liver respectively. Local retention was related to LE. Improved score
values  were found after lymphatic vessel implantation.
Conclusions: LS is a clinically useful method to diagnose LE of the lower limb in
pediatric patients, it contributes to better understanding of pathomechanism of the
LE. LS has therapeutic impact and is helpful in the postoperative follow-up.
THE PROGNOSTIC IMPORTANCE OF THE SENTINEL
LYMPH NODE EXAMINATION IN BREAST CANCER
E. Boda1, A. Medveczki1, F. Jakab2, K. Pócza3, L. Landherr4, I. Balogh1
Uzsoki Street Teaching Hospital:
1Department of Nuclear Medicine
2Department of Surgery
3Department of Pathology
4Department of Oncology
Aim: We evaluated in breast cancer using sentinel lymph node biopsy (SLNB) fol-
lowed by full axillary resection: 1. the removed sentinel lymph node(s) (SLN) positiv-
ity with conventional and serial sectioning and immunhistochemical staining 2. the
number of cases with false positive SLN 3. the frequency of loco-regional and dis-
tant spread of the tumor during 3 years follow-up period
Material and methods: SLNB were performed in Uzsoki Hospital between 1999
and 2004 in 381 cases. In this study we evaluated the results of histological exam-
inations of SLN, and bone scintigraphy, abdominal and axillary ultrasonography,
chest X-ray examination repeated every year in the cases of breast cancer with <
25 mm tumor, clinical NO stage. The mean follow-up period was 3 years. The num-
ber of pts was 98, mean age 52 year (35–82 years). In breast cancer (verified by
mammography, ultrasonography and cytology examinations) we injected 150 MBq
Tc-99m-SentiScint intradermally-peritumorally or intratumorally in the cases with non
or poorly palpable tumor. After 3, 24 hours we performed static scintigram with
gamma camera. We removed the SLN intraoperative, looking for node(s) with gam-
ma probe, NAVIGATOR. We analysed the removed SLN by histological method
(conventionally and immunhistochemically). The oncological treatment was modi-
fied by the histological result of SLN.
Results: We could find positive SLN in 29/98 (29%) patients, the SLN were false
negative in 4/98 (4%) patients. During 3 years follow-up period we could not detect
local metastases, in 1 case the metastases were found in axilla, in 3 cases distant
metastases could be detected.
Conclusions: Our results proved to be almost the same as in the literature in the
cases with clinicaly NO stage of breast cancer — showing positive SLN in 28% of
patients, the low number of pts with regional and distant metastases. Using the
SLNB the staging of the breast cancer can be more accurate, therefore the onco-
logical therapy can be more adequate as well.
SENTINEL NODE DETECTION IN BREAST CANCER: PERITUMORAL
VS. PERIAREOLAR TRACER ADMINISTRATION TECHNIQUE
T. Jastrzębski1, T. Bandurski2, P. Lass2
1Department of Surgical Oncology
2Department of Nuclear Medicine, Medical University, Gdańsk, Poland
Background and aim: Regional lymphatic node resection is a standard manage-
ment in surgical treatment of breast cancer. Sentinel node determination is an im-
portant part of it. The aim of the study was to compare the radionuclide and blue
dye techniques of as well as the influence of the way of tracer administration on the
sensitivity of sentinel node determination.
Material and methods: We studied 195 patients with breast carcinoma divided
into three groups: group I (51 patients) with radionuclide/blue dye peritumoral ad-
ministration, group II (72 patients), with sentinel node determined with blue dye
technique only, group III (72 patients), where radionuclide and blue dye were inject-
ed intradermal and peri-areolar way. 99Tc-nanocolloid tracer and a single head
gamma-camera Diacam (Siemens, Germany) were applied; intra-operation senti-
nel node determination was done using a hand-held NeoProbe device.
Results: Sensitivity, specificity, positive and negative predictive ratios were respec-
tively in group I: 92%, 100%, 100% i 96%; in group II: 72%, 100%, 100% i 81%, in
group III 91%, 100%, 100%, 95%.  Multivariant analysis showed that efficacy of
sentinel node determination depended on body mass index and surgeon’s experi-
ence, did not on age of patient, the size of the tumour and it’s pathologic type.
Conclusions:  Dual radionuclide/blue dye sentinel node determination technique is
superior to blue dye only technique, with no major impact of the way of administra-
tion.
LYMPHATIC RECURRENCE IN MALIGNANT MELANOMA FOLLOWING
SELECTIVE  LYMPH NODE DISSECTION BASED ON SENTINEL NODE
BIOPSY
E.W. Tekle1, M. Rajtár1, M. Sinkó1, G. Kosztolanyi2
1Bács-Kiskun County Hospital
2Departments of Nuclear Medicine and Dermato-Surgery, Kecskemét
Aim: To evaluate the occurence of lymphatic region recurrence during postopera-
tive follow-up in patients with 1-4 mm thick malignant melanoma (MM) and without
palpable regional lymph node,  omitted regional block dissection (RBD) based on
negative result of sentinel node biopsy (SNB).
Material and methods: Between April 2001 and November 2003 selective RBD
was performed in 47 MM patients, i.e. RBD was omitted in patients with negative
sentinel node(s) (SN). Combined method was used (Tc99m labelled nanocolloid was
injected peritumorally or round the scar on the day before the operation + blue dye
was injected peritumorally or round the scar directly before the operation). Hot and
blue lymph nodes only were identified as sentinel nodes. In 28/47 patients RBD was
omitted based on negative results of SN histology completed after the operation. In
28 patients physical examination, lymph node region as well as abdominal ultra-
sound (US), chest X-ray, bone scan and S-100 protein measurement were per-
formed during the follow-up. The mean of duration of follow-up was 24 months
(range, 10–41 months).
Results: Suspicion of lymph node region recurrence was raised in 4/28 patients
according to physical examination and lymph node region US. The cytology was
negative in 3/4 patients (histiocytosis, non malignant disease) and lymph node me-
tastasis in 1/4 patient. In the latter case lymphatic region recurrence as well as scar
recurrence was revealed at the same time therefore it is impossible to hold an opi-
nion about the possibility of a false negative SNB.
Conclusions: Our results support that: 1. Using strict patient enrollment, 2. Using
combined radiocolloid and blue dye labelling technique, 3. With properly trained
team, selective RNB based on SNB is a safe and appropriate method in early MM.
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RADIONUCLIDE GASTRIC EMTYING STUDIES IN DIABETES MELLITUS
M. Papós1, 2, T. Várkonyi3, M. Lázár1, 2, R. Takács3, R. Róka3, P. Légrády3,
C. Lengyel3, J. Lonovics3, L. Pávics1, 2
1IMC Szeged
2Department of Nuclear Medicine
31st Department of Medicine, University of Szeged, Szeged
Aim: The diagnostic role of radionuclide gastric emptying study was investigated in
long duration type 1 and type 2 diabetes mellitus (DM) patients for the determina-
tion of diabetic neuropathy.
Material and methods: Twenty-two patients has type 1 DM and 13 patients su-
ffered from type 2 DM. The duration of disease was similar in two group of patients
(type 1: 23.5 ± 1.8 years, type 2: 19.6 ± 2.5 years, p > 0.5). The dynamic of gastric
emptying was investigated after eating of two 99mTc-labelled boiled eggs, one roll
of bred, and 200 ml of water. The gastric emptying was characterised by the half
time of the gastric time/activity curve. The gastric half time was compared with the
results of cardiovascular reflex tests (AN score).
Results: The gastric half time was increased in both groups (type 1: 95 ±  9.9, vs.
49.6 ± 5.5 min, p < 0.05, type 2: 82.4 ± 8.8 vs. 49.6 ± 5.5 min, p < 0.05). The AN
score revealed more severe neuropathy in the type 2 DM (type-1: 4.3 ± 0.6, type 2
7.1 ± 0.5, p < 0.01). A significant positive correlation was found between the gas-
tric emptying and the AN score in the type-1 DM (r = 0.57, p < 0.01). No correlation
was detected between the gastric emptying and the AN score in the type 2 DM
patients.
Conclusions: The gastric emptying was prolonged in both groups of DM patients.
In type 1 DM the AN is suggested to be the initial factor of gastoparesis. In the type 2,
the ethiology of gastroparesis is more complex.
SPECT STUDIES IN FOCAL NODULAR HYPERPLASIA
E. Schmidt, E. Udvaros, Z. Szabó, K. Zámbó
Department of Nuclear Medicine Medical Faculty, University of Pécs
The focal nodular hyperplasia (FNH) is the second most common benign hepatic
tumor, which contains variable quantities of normal hepatic cellular elements: Kupffer
cells, hepatocytes, bile ducts and blood vessels. Nuclear medicine has an impor-
tant role in the diagnostic of FNH. The caracterictic signes are increased perfusion,
normal or moderately increased blood pool and increased accumulation of 99mTc-
-HIDA. The colloid uptake is in approximately 75% of cases normal, in 25% de-
creased, and in 5% increased, reflecting the variable quantity of Kupffer cells.
Two patients with suspicion of FNH were investigated by colloidal-, blood pool- and
hepatobiliary scintigraphy. Static and SPECT study were performed in all cases.
Diagnosis was confirmed by histology. In our experience the SPECT study is an
useful completion of static study aspecially in small tumors, in the exact apprecia-
tion of activity.
HEPATOBILIARY SCINTIGRAPHY COMBINED WITH DRINKING OF MILK
IN PATIENTS WITH “POSTCHOLECYSTECTOMY SYNDROME”
I. Földes, A. Lévay
BM. Hospital, Department of Nuclear Medicine, Budapest
Aim: After cholecystectomy a compensating dilatation of the bile ducts may occur.
The obstruction of the bile flow also results in dilatation of the bile ducts. Hepato-
cholescintigraphy combined with drinking of milk was used to differentiate between
the to possibilities.
Material and methods: 48 patients with „postcholecystectomy” complaints were
enrolled into the study. 100 MBq 99m-Tc-EHIDA was injected i.v, 90 frames (1 min
each ) were registered 250 ml milk was given at the moment when the activity in the
common bile duct started to decrease. The time from the injection to the arrival into
the duodenum was measured, more than 25 minutes was regarded as a delay. The
half time of ejection after milk was also determined in the common bile duct. The
ejection showed a fast and a slow component. The upper normal value of the fast
component half time is 10 min, and that is 20 min for the slow component.
Results: In 28 subjects all the three parameters of the bile flow were in the normal
range. In 6 patients all were delayed and in these patients partial obstruction of bile
flow was diagnosed. In 6 patients the delayed arrival of isotope was combined with
normal ejection after milk, these data together were not regarded as an obstruction.
The fourth type of the results was  the arrival in time with delayed ejection The slow
ejection was the sign of partial obstruction (8 patients).
Conclusion: The measuring of the arrival of the isotope into the duodenum com-
bined with the determination of the ejection rate after drinking milk makes the biliary
scintigraphy suitable to differentiate obstruction from biliary tract dilatation observed
following cholecystectomy.
GASTROENTEROLOGY
COMPARISON OF VARIOUS MEASURES
AND INDICES OF KIDNEY FUNCTION
J. Varga1, L. Újhelyi2, J. Mátyus2, L. Galuska1
1Department of Nuclear Medicine
21st Department of Medicine University of Debrecen, Hungary
Aim: Various indices of the kidney function have been developed and used in the
clinical practice. Our aim was to compare nine of these methods in order to find
those of choice for the everyday routine.
Material and methods: 31 patients in states ranging from normal to serious renal
insufficiency were studied. Tc-99m DTPA clearance from two blood samples (DTPA-
-GFR) was used as reference. Gamma camera-based techniques included Gates’,
Inoue’s and Patlak analysis. Non-radioactive measurements of creatinine clearance
(without and with normalization), Cystatine-C, and indices using the MDRD and
Cockroft-Gault (CG) formulas were also calculated. Regression analysis and Alt-
man-Bland plot were used to characterize the relationship with the reference meth-
od. From among the split renal function estimators the one based on the Patlak plot
was used as reference.
Results: All studied methods correlated significantly with DTPA-GFR. MDRD (0.88),
Cystatine-C (0.78) and CG (0.75) showed the highest correlation coefficients. From
among the camera-based methods Inoue’s performed the best (r = 0.69), while
Gates’ the poorest (r = 0.54). All parameters but CG and Inoue’s method were
significantly biased proportional to GFR; e.g. MDRD tends to overestimate values
below 60, while underestimate those above 60 ml/min/1.73 m2. Gates’ method for
split renal function tends to overestimate the side of worse function, although not
significantly.
Conclusion: From among the laboratory parameters tested the MDRD formula pro-
vided the best estimate of GFR. From the present gamma camera-based tech-
niques Inoue’s is the method of choice.
KIDNEYS
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INFECTION AND INFLAMMATION
THE ROLE OF LEUKOCYTE SCINTIGRAPHY IN THE DIAGNOSIS
OF VASCULAR GRAFT INFECTION
M. Papós1, 2, Z. Hódi3, M. Lázár1, 2, Z. Besenyi1, 2, R. Sipka3, G. Lázár3,
L. Pávics1, 2
1IMC, Szeged
2Department of Nuclear Medicine
3Department of Surgery, University of Szeged, Szeged
Aim: The diagnosis of vascular graft infection is not always easy. While the graft
infection indicates hazardous reoperation, the correct diagnosis is essential. In this
study, the diagnostic value of 99mTc-HMPAO leukocyte scintigraphy (LS) was ana-
lysed in cases with graft infection.
Material and methods: Ten patients (11 grafts: 6 aorto-bifemorale, 3 femoro-
popliteal, 2 ilio-femorale) were investigated. Images were taken 2, 4 and 24 hours
following the reinjection of in vitro labelled leukocytes. The results of LS was com-
pared with the surgical and bacteriological findings.
Results: LS revealed infection in 9 of the 10 patients, in concerning to 10 grafts. The
reoperation and bacteriology verified infection in 8 patients (9 grafts). In one case,
LS was false positive: during the reoperation scar tissue was found without infec-
tion. In another patient LS was false negative. In true positive cases, LS correctly
localised the site of infection.
Conclusions: LS is a sensitive method for the verification and localisation of vascu-
lar graft infection. Further investigations are necessary to confirm the specificity of
LS in graft infection.
PREPARATION AND STUDY OF 99M-TC-LABELLED COMPLEXES
FOR INFLAMMATION AND INFECTION IMAGING
L. Korösi, L. Balogh, D. Máthé, A. Polyák, Gy. A. Jánoki
„F.J.” National Center of Public Health, National „F.J.C.” Research Institute for
Radiobiology and Radiohygiene, Budapest
According to the report of WHO, 25% of all deaths world wide are caused by infec-
tious deseases. The aim of IAEA supported Coordinated Research Programme
developing specific radiopharmaceuticals in the field inflammation and infection
imaging. We tested the following agents: Human Neutrophil Elastase 2 (HNE2),
Ubiquicidin (UBI). We used next chelating agents: diethylen-triamine penta acetic
acid (DTPA), 6-hydrazinopyridine-3-carboxylic acid (HYNIC).In ther first step HNE2
and UBI were conjugated with chelating agents. We prepared next conjugates
HNE2-DTPA, UBI-DTPA, UBI-HYNIC. After stability studies of conjugated peptides
we worked out optimum conditions of labelling procedure with 99m-Tc. We accom-
plished radioanalitycal and chemical stability examination of radiolabelled conju-
gates. Radioanalitycal mehods were worked with HRLC, ITLC, paper cromatogra-
phy. Scintigraphical examination studies were done in inflammation induced rats,
and Beagle dogs. All the compounds tested showed labelling efficiency higher than
95% but HNE2-DTPA showed after six hours 94–95%. Scintigraphical examination
studies with HNE2-DTPA twenty four hours after injecting higher activity showed
inflammation induced field. We can conclude that 99m-Tc-HNE2-DTPA have the
potential radiopharmaceutical for inflammation and infection imaging.
RELATIONSHIP BETWEEN THE BONE STRENGTH AND BONE MINERAL
CONTENT IN EXPERIMENTALLY INDUCED OSTEOPOROSIS IN RATS
V. Ferencz1, B. Kári2, G. Érdi2, Sz. Mészáros1, J. Gaál3, F. Szalay1,  Á. Mester2,
E. Máté4, C. Horváth1
1Semmelweis University, Ist Department of Internal Medicine
2Semmelweis University, Department of Diagnostic Radiology and Oncotherapy
3Budapest University of Technology and Economics, Polymer Engineering and
Textile Techn.
4University of Szeged, Department of Applied Informatics
Main aim of the research work was to investigate the relationship between bone
strength and bone mineral content at different skeletal sites in experimentally in-
duced osteoporosis in rats  Bone mineral contents (BMC) have been determined
by single photon absorptiometry at femoral metaphysic, as well as another physi-
cal quantity at the trochanter to be proportional very well to the bone mineral mass
was tested by a soft X-ray equipment in case of cirrhotic rats. The exposed X-ray
films were digitised and then quantitatively evaluated by OSIRIS 3.6 and microSe-
gams© imaging systems. Next investigations were oriented to determine the ma-
ximal mechanical loading forces (Fmax) by a biomechanical test series (Zwick-020)
at femoral metaphysis. The obtained results have been compared to normal con-
trol groups.
High correlations were found in normal control group between cortical BMC and
metaphyseal Fmax (r = 0.901, p < 0.001) as well as between cancellous (trochan-
teric) bone mass and metaphyseal Fmax (r = 0.906, p = 0.002). Strong correlation
was obtained also between cortical and cancellous bone mass (r = 0.809,
p = 0.015) at femora of control rats. However, in case of cirrhotic animals only
cortical BMC showed relationship to metaphyseal Fmax (r = 0.769, p = 0.003)
while no correlation was found between cortical and trochanteric bone mass.
The obtained results show strong relation between maximal loading force of femo-
ral metaphysic and cortical as well as trabecular bone density for normal control
group. In turn, the cortical and trabecular bone loss in cirrhotic animals are not
equivalent. Consequently, the maximal loading force of bone metaphyseal cannot
be determined by trabecular bone density.
BONE AND JOINTS
ACTIVITY DEFECT ON BONE MARROW SCINTIGRAPHY:
VERTEBRAL HAEMANGIOMA?
E. Palócz, T. Györke, K. Karlinger, Á. Mester, K. Kiss, E. Lahm, E. Makó
Semmelweis University, Department of Diagnostic Radiology and Oncotherapy,
Budapest
Aim: Focal decreased activities on bone marrow scintigraphy (BMS) suspicious for
bone metastases (BM) can be caused by several benign lesions. Recently vertebral
haemangiomas (VH) could be proved in several cases as the cause of focally de-
creased bone marrow uptake on BMSs performed with the suspicion of BMs.
Nevertheless such cases are not reported in the literature. Based on our cases the
diagnostic features of VHs will be discussed.
Material and methods: The BMSs performed in 2003–2004 were overviewed. BMS
was performed 2–3 hours after the intravenous application of 700 MBq
Tc-99m labelled anti-granulocyte antibodies. Whole body- and occasionally SPECT
images  were obtained. Suspicious metastatic lesions were further investigated
radiologically.
Results: We performed 64 BMSs in 2003 and 2004. All patients with BMS had bone
scintigraphy (BS) previously. 5 focal decreased bone marrow uptake of 4 patients
were caused by VHs as proved by radiology (2 X-ray, 4 CT, 3 MR). 2 additional bone
marrow- and 1 bone SPECT were performed. The activity defect caused by VH was
depicted in a single vertebral body but BS showed almost normal regional uptake.
Our cases demonstrate the more specific radiological features of VHs as well.
Conclusions: We found VH frequently in our patient population. Among focal acti-
vity defects on BMS VHs and BMs have similar appearance while degenerative
lesions can  cause more specific image based on photopenic lesions in two neigh-
bouring vertebral bodies. According to our experiences and literature data BSs are
usually normal in the region of VHs but early BMs may also  have the same appear-
ance. One or few lesions detected on BMS necessitate further clarifying investiga-
tions.
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THERAPY
SAMARIUM-153-MULTIBONE TREATMENT OF METASTATIC BONE PAIN
I. Garai, L. Szabados, C. András, G. Péter-Szarka, J. Varga, L. Galuska
Department of Nuclear Medicine and Oncology, University of Debrecen
Background: Pain caused by bone metastases often significantly affects quality of
life of the patients with cancer. In Hungary the isotopic treatment of this type of pain
is reimbursed by the national security system for 3 years.
Aim: To follow-up of our patients treated with Sm-153-Multibone and to determine
of therapy efficacy and the extent bone marrow damage.
Material and methods: Between 2002–2004 we performed 90 treatments in
74 patients, In most cases primary cancer causing metastasis was breast cancer
among women (26 patients) and prostatic cancer (24 patients) in men. 43 patients
were already on narcotic drugs, the others received multiple types and doses of
analgesics. The bone scintigraphy score before treatment was mean 69 (30–110).
The patients received 2500 MBq Sm-153-Multibone intravenously. 10 patients asked
for treatment repetition.
Results: The decrease of subjective complaints and reduction in analgesic con-
sumption was the marker of treatment efficacy.The therapy was succesfull in 48
patients (significant pain reduction in 33, moderate pain reduction in 15 patients).
Succesfull treatment was achieved mostly in breast and prostatic cancer, while
failure was seen mainly in metastases caused by other tumors (colo-rectal, thyroid
carcinoma). In one part of our cases the repeated bone scintigraphy showed signi-
ficant regression. After the treatment 30% of patients had the significant lowering of
the white cell and thrombocyte counts. It could be noticed in the 2nd weeks after the
treatment and reached critical values in the 4th week. The red blood cell counts and
serum creatitine levels did not change.
Conclusion: Based on our results, Samarium-153-Multibone treatment is effective
for bone pain palliative therapy, but the reduction of white blood cells requires close
follow up of the patients.
ó
2.5-YEARS RESULTS WITH 166HOLMIUM-PHYTATE TREATMENT
OF CHRONIC SYNOVITIS. PHASE I-IIA, RANDOMIZED, INCREASING
DOSAGE, SINGLE-BLIND, PLACEBO-CONTROLLED COMPARATIVE
STUDY
M. Szentesi1, S. Takács1, Z. Farbaky1,  E. Nagy1, J. Környei2, M. Antalffy2,
J. Törko2, G. Tóth2, G. Jánoki3, L. Balogh3, P. Géher1
1Semmelweis University, Chair of Rheumatology and Physiotherapy, Department
of Rheumatology, Polyclinic of the Hospitaller Brothers of St. John of God
2Institute of Isotopes Co. Ltd.
3National FJC Research Institute for Radiobiology and Radiohygiene Budapest,
Hungary
Study objectives: Examination of anti-inflammatory effect of 166-Holmium-phytate
injection /166-Ho/.
Material and methods: Phases I-II, randomized, simple-blind, placebo-controlled
comparative study using increasing dosage. 31 patients suffering from chronic syn-
ovitis, rheumatoid arthritis and seronegative spondylarthritis were examined. The
protocol commenced with screening. The patients were selected according to in-
clusion and exclusion criteria. Patients were randomly distributed into four treat-
ment arms: Group I. Holmium phytate injectable suspension marked by 185 MBq
166Ho + 40 mg of 1 ml triamcinolone acetonide/TA/ + 1 ml of 1% lidocaine injec-
tion./Lid.inj./ Group II. 555 MBq 166Ho. + 40 mg of 1 ml TA + 1 ml Lid.inj. Group III.
925 MBq 166Ho + 40 mg 1 ml TA + 1 ml of 1% Lid.inj. Group IV. Solely 40 mg of 1 ml
TA + 1 ml of 1% Lid.inj. There were 30 month follow-up period after the administra-
tion of the isotope. Inflammatory activity of the affected knee-joint was tested prior
to treatment, and the 14th and 28th days, and 3, 6, 9, 12, 24 and 30 months after
treatment. Testing was done based on the following parameters: Measurement of
swelling of knee-joint [cm]; Flexion – heal buttocks distance [cm]; Degree of knee-
-joint pain. Visual Analogue Scale /VAS-1-100/; Patient’s opinion on inflammation of
knee-joint /VAS-1-100/; Doctor’s opinion on given inflammation of knee-joint /VAS-
-1-100/.
Results: Even after 3 year period 88.2% of the findings were rated as excellent or
good. 86.66% of the patients do not need another punction even after a 3 years
period. During the study period, inflammation decreased in the group receiving
555 and 925 MBq.
Conclusion: Ho-166 isotope is an effective radiopharmacy treating synovitis. Effec-
tive dosage is 555-925 MBq.
INTRACORONARY RADIONUCLIDE THERAPY WITH LIQUIDE RE-188 TO
PREVENT RESTENOSIS
Z. Nagy1, Z. Varga1, K. Buga1, G. Bokori1, F. Molnár2, L. Major2, I. Préda2,
I. Szilvási2
1National Medical Center, Department of Nuclear Medicine
2Cardiovascular Center, Budapest
Aim: To evaluate possible relationship between clinical success of intracoronary
radionuclide therapy with liquide Re-188 to prevent restenosis (RS) after percutane-
ous coronary intervention (PCI) and severity of coronary artery disease (length of
stenosis, number of diseased vessels and restenosis after previous PCI).
Material and methods: 19 patients (11 male, 8 female, median age: 64.1 years)
were enrolled in the study according to the protocol of an IAEA co-ordinated project.
13 patients had significant coronary stenosis with less than 2 cm of length, 6 pa-
tients had stenosis longer than 2 cm. 8 patients had single vessel, 5 patients had
two-vessel and 6 patients had three-vessel disease. 5 patient had RT after one, 10
after two and 4 after three previous PCIs. 18–20 mL of Re-188 eluate from a W-188
generator were concentrated to 1–2 mL. Re-188 solution was put — by a special
tool with appropriate radiation protection — into a balloon-catheter placed in the
dilated vessel. Duration of the irradiation was calculated by an Excel table — based
on certain data of the coronary anatomy and radioactive concentration — to deliver
18 Gy to the vessel. Success of the therapy was evaluated after 6 month of follow-up.
Results: 6 patient had RS. RS rate was not related to the length of stenosis. RS
occured in patient with two- or three-vessel disease and after 2 or 3 previous res-
tenosis only.
Conclusions: intracoronary radionuclide therapy is not effective in patients with
two- or three-vessel disease and repeated restenosis after previous PCI.  Suppor-
ted by IAEA (CRP-IVRNT).
ó
166HOLMIUM-PHYTATE-RADIOSYNOVIORTHESIS IN RHEUMATOID
ARTHRITIS. ONE YEAR RESULTS. PHASE III PROSPECTIV STUDY
M. Szentesi1,  S. Takács1,  Z. Farbaky1,  E. Nagy1, J. Környei2, M. Antalffy2, J. Törko2,
G. Jánoki3,  L. Balogh3, P. Géher1
1Semmelweis University, Chair of Rheumatology and Physiotherapy, Department
of Rheumatology, Polyclinic of the Hospitaller Brothers of St. John of God
2Institute of Isotopes Co. Ltd
3National FJC Research Institute for Radiobiology and Radiohygiene Budapest,
Hungary
Study objectives: Examination of anti-inflammatory effect of 166-Holmium-phytate
injection.
Material and methods: Phases III, prospectiv study. 32 patients suffering from
chronic synovitis, rheumatoid arthritis were examined. The protocol commenced
with screening. The patients were selected according to inclusion and exclusion
criteria. Holmium phytate injectable suspension marked by 600 MBq 166Holmium
phytate injectable suspension, and 40 mg of 1 ml triamcinolone acetonide and 1 ml
of lidocaine 1% There were 12 month follow-up period after the administration of the
isotope. Inflammatory activity of the affected knee-joint was tested prior to treat-
ment, and the 3th and 3, 6, 9 and 12 months after treatment. Evaulation was based
on the criteria as described by Müller, Rau and Scütte the score system was devel-
oped by the authors.
Results: During the study period, inflammation decreased. In the first one year ex-
cellent and good results were recorded in 93.3%. One year after radiosynoviorthe-
sis 93.3% of patients did not need another punction. Administration of Holmium-
166 phytate is a safe procedure. We did not detect any symptoms of radiation
sickness. We found no deviations in either haematological or chemical parameters
during the study period.
Conclusion: Holmium-166 isotope is an effective radiopharmacy treating synovitis.
Due its adventageous features it produces less radioactive damage on the orga-
nism than the traditionally used isotopes (90-Yttrium, 169-Erbium, 186-Rhenium).
Due to its physical parameters it is optimal to treat large joints (knee) and medium
size joints (hips, shoulder, elbow, wrist, ankle). Effective dosage is 555–925 MBq.
THERAPY — RADIOSYNOVIORTHESIS
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THE STRATEGY OF THE DIAGNOSTIC METHODS BEFORE
RADIOSYNOVIORTHESIS (WHICH EXAMINATIONS SHOULD WE MAKE,
WHICH ARE ENOUGH?)
C. Komora1, G. Kovács1, I. Szerb2, I. Balogh1
1Uzsoki Street Teaching Hospital, Department of Nuclear Medicine
2Orthopedy
Background: The radiosynoviorthesis (RSO) has been used effectively for a long
time for the treatment of the painful arthropathy, synovitis. The indication and the
isotops for the usage are well-defined. The effectiveness of the RSO depend on the
good indication of the treatment. We have to decide before the therapy the diagno-
sis perfectly and the good distribution of the isotop inside the joint.
Aim: To decide the indication of RSO exactly with the shortest, most accurate diag-
nostic strategy.
Material and methods: On the basis of clinical status, we examined before treat-
ment of 81 patients, dedicated for knee RSO 52 patients, for hip 25 patients, for
ankle 4 patients. In every case we performed X-ray (XR), ultrasonography (US),
three phase bone scintigraphy (BSc). In 6/81 cases MR was performed as well.
Results: 1. XR examinations help select the relative contraindicated cases (for
example: subluxations).
2. US compared whit BSc detected more exatly the synovitis.
3. We could find good correlation between the severity of pain caused by synovitis
and the early phase of BSc.
4. The other intra- or extrajoint illnesses in contrary to synovitis could be detected by
US exactly.
5. BSc can differentiate the main cause of pain in the cases of association of syno-
vitis and arthrosis (painful synovitis or painful arthrosis?)
6.US proved to be the only diagnostic method to detect Baker-cysts. On the basis
of these 3 examinations in 17/81 cases the RSO were contraindicated or non-indi-
cated.
Conclusions: The XR and US examination are proved to be the first, most impor-
tant „screening” method before RSO. The BSc should be performed to detect:
1. The severity of the well established synovitis
2. The localisation of the real cause of the pain
3. To decide the sequence of treatment in the case of more than one joints to treat.
The importance of other (MR or something else) examinations is very low.
ULTRASOUND MONITORING OF THE SYNOVIAL THICKNESS AFTER
166-HOLMIUM-PHYTATE RADIOSYNOVIORTHESIS — 2.5-YEARS
RESULTS (COMPARATIVE, RANDOMIZED, SINGLE-BLIND, PLACEBO-
-CONTROLLED STUDY WITH INCREASING DOSAGE)
M. Szentesi, Z. Farbaky, I. Buday, S. Takács, E. Nagy, P. Géher
Semmelweis University, Chair of Rheumatology and Physiotherapy, Department
of Rheumatology, Polyclinic of the Hospitaller Brothers of St. John of God,
Budapest, Hungary.
Study objectives: Measure the synovial thickness after 166-Holmium radiosynovior-
thesis by sonography.
Material and methods: Phase I-II, randomized, simple-blind, placebo-controlled
comparative study using increasing dosage. 31 patients suffering from chronic syno-
vitis, or rheumatoid arthritis /RA/, or seronegative spondylarthritis (SNSA) were ex-
amined. The protocol commenced with screening. The patients were selected ac-
cording to inclusion and exclusion criteria. Patients were randomly distributed into
four treatment arms: Group I. 185 MBq 166Holmium phytate injectable suspension
and 40 mg of 1 ml triamcinolone acetonide, and 1 ml of lidocaine injection 1%
Group II. 555 MBq 166Holmium phytate injectable suspension, and 40 mg of 1 ml
triamcinolone acetonide and 1 ml of lidocaine 1% Group III. 925 MBq 166Holmium
phytate injectable suspension and 40 mg of 1 ml triamcinolone acetonide and 1 ml
of lidocaine 1%. Group IV. Solely 40 mg of 1 ml triamcinolone acetonide and 1 ml of
lidocaine injection 1%. There were 30 month follow-up period after the administra-
tion of the isotope. We measured the quantity of the synovial fluid and the thickness
of the synovia before the treatment, and the 14th, 28th days and 3, 6, 9, 12, 24 and
30 months after the treatment. We measured the synovial thickness the following loca-
tions: In the midline, lateral and medial, by the condylus of femur medial and lateral.
Results: The thickness of the synovia decreased significantly in the Group II
(555 MBq) and III (925 MBq). After a transient improve (the steroid effect) the thick-
ness of the synovia began to rise in the Group I. (185 MBq) and in the control group.
We find a significant correlation between the synovial thickness and the clinical
improvenes.
Conclusion: The 166-Holmium-phytate is an effective new radiopharmacon in the
treatment of synovitis. We detect the clinical improvement by sonography.
The effective dose is 555-925 MBq.
RESULTS OF ONE YEAR  FOLLOW-UP — RADIOSYNOVECTOMY
IN KNEE AND HIP JOINT
I. Szerb1, C. Komora2, G. Kovács2, I. Balogh1
1Uzsoki Street Teaching Hospital Orthopedy
2Department of Nuclear Medicine
Aim: One year follow-up results of 65 pts treated with radiosynovectomy  were eva-
luated. In 17/65 cases the hip and in 46/65 cases the knee were treated.
Material and methods: The indication of radiosynovectomy was synovitis in sys-
temic disease (PCP, SNSA, psoriatic arthritis) in 21/65 cases or in  early stage of
arthrosis in 41/65 cases. Mean age was 49 year (30–82), 51 female, 14 male. Be-
fore the treatment X-ray examinations, 3 phase bone scintigraphy and ultrasonog-
raphy were made in every case. Yttrium-90-colloid was used for radiosynovectomy
of hip and Rhenium-186-colloid for radiosynovectomy of knee. Measurement of
clinical improvement was performed with HSS (Hospital for Special Surgery) score.
3 phase bone scintigraphy and ultrasonography were repeated after 3–6 months.
Results: On the basis of clinical improvement our cases were divided into 3 groups:
1. best clinical effect (HSS score 80–100), 2. intermediate therapeutical  effect (HSS
score 60–80), 3. low therapeutical effect (HSS score 40–60). We could register in
52/65 (80%) of patients clinical  improvement 1-3. score in HSS score system with
improved mobility, pain, inflammation, oedema. Ultrasonography and 3 phase bone
scintigraphy had good correlation with the clinical status.
Conclusion: On the basis of objective clinical scoring, and results of diagnostic
procedures (3 phase bone scintigraphy and ultrasonography) radiosynovectomy
of hip and knee was proved to be a good alternative method for the treatment of
synovitis.
USE OF A TUMOROUS DOG MODEL IN THE EVALUATION
OF 90Y AND 99MTC-LABELLED SOMATOSTATIN ANALOGS
D. Máthé, A. Polyák, L. Balogh, R. Király, G.A. Jánoki
”F.J.” National Center of Public Health, National „F.J.C.” Research Institute
for Radiobiology and Radiohygiene, Budapest
Background: There is a considerable interest about matching pairs of diagnostic
and therapeutic radiopharmaceuticals for targeted somatostatin receptor therapies.
However, there is a gap in preclinical models between the monoclonal, well-reac-
ting rodent-borne tumors and the real clinical situation, where polyclonal and stro-
ma-containing tumors have to be killed by radionuclide receptor therapy. We aimed
at filling this gap with the presentation of a dog insulinoma diagnosis and treatment
with radiolabelled somatostatin analogs.
Material and methods: The labelling of the somatostatin analog peptide DOTA-
-TATE  (piChem, Austria) was performed with 90Y for therapeutic goals under mildly
acidic conditions and heating. 99mTc labelling of the peptide HYNIC-TATE (Kanton-
sspital Basel, Switzerland) was performed by the method described by the supplier.
One dog bearing insulinoma received two doses of subsequently 10 and 5 mCi of
90Y-DOTA-TATE. A diagnostic scintigraphy and SPECT was performed in the ani-
mal with 500 MBq of 99mTc-HYNIC-TATE. Size of the tumor was monitored by ultra-
sound. Blood kinetics of the pharmacons were measured. Serum insulin and glu-
cose as well as a complete biochemistry panel were monitored, too.
Results: Following the first two therapies, the tumor size of originally 1.8 cm in
diameter shrinked and after 2 months the tumor became unvisible with ultrasound.
Serum insulin levels decreased shortly after therapies, but returned to an elevated
level thereafter. The animal was free of symptoms for 1 year following treatment.
However, 99mTc-HYNIC-TATE SPECT has shown a small focus in this period.
Discussion: This case reveals the use of a large animal model in targeted cancer
treatment and the effectiveness of somatostatin receptor therapy.
VETERINARY NUCLEAR MEDICINE
72
Nuclear Medicine Review 2005, Vol. 8, No. 1
www.nmr.viamedica.pl
Abstracts
69
7271
70
SENTINEL LYMPH NODE DETECTION IN DOGS AND CATS
— RETROSPECTICE ANALYSIS OF CLINICAL CASES
L. Balogh, D. Máthé, G. Andócs, J. Thuróczy, E. Perge, A. Polyák, R. Király,
G.A. Jánoki
”F J” National Center of Health, National ”F.J.C.” Research Institute for
Radiobiology and Radiohygiene, Budapest
The aim of this study was to compare the effectivity of detection sentinel lymph
nodes by radioactive, non-isotope and a mixed method in spontaneously occurring
oncological canine and feline patients and to evaluate the clinical usefulness of
a novel method. Altogether 44 dog and 21 cat patients with the history of mammary
tumours, skin tumours and different head-, and neck tumours were included in the
study. All the referred patients underwent fine needle biopsy, thoracal radiography
and haematological examination before the surgical removal and intra-operative
sentinel lymph node detection. Gamma camera imaging (Nucline X-ring, Mediso
Ltd) and intra-operative gamma probe (Europrobe, Eurorad) with blue stain ima-
ging (Patent blue) was used for localizing the sentinel nodes. Removed tumours
and lymph nodes were investigated by pathologist. Forty two percentage of the
removed lymph nodes found to be positive by histopathological examination. Only
62% of the lymph nodes were enlarged, palpable before the surgery, and 70% were
blue colour painted by the stain. Seventy six % of the nodes were imaged in the
preoperative scans and over 96% were to be localized by the combined (99mTc-colloid
and blue stain) intra-operative detection. All the 5 lymph nodes that were not detect-
ed by any methods but found by the pathologist in the surgical samples were neg-
ative for metastases. Only 1 patient with negative sentinel lymph nodes resulted
regional recurrance of the tumour and over 50% of the positive sentinel lymph nodes
resulted local recurrance in the 2 years follow-up examinations. Intra-operative ra-
dioactive guided surgery combined with gamma camera imaging and the blue stain
seem to be the superior method for localizing sentinel lymph nodes. The use of
sentinel lymph node detection in animals proved to be helpful in the veterinary on-
cological praxis.
STUDIES OF LOCAL HYPERTHERMIA’S EFFECTS ON THE UPTAKE
OF 99MTC-MDP WITH 3-PHASE BONE SCINTIGRAPHY IN THE HEALTHY
BEAGLE DOG
D. Máthé, M. Hajnal, M. Gerhardt, M. Whelan, L. Balogh, M. Zürn, D. Albrecht,
G.A. Jánoki
“F.J.” National Center of Public Health — “F.J.C.” National Research Institute for
Radiobiology and Radiohygiene
Background: Application of local hyperthermic protocols is gaining an increased
reputation in oncotherapy of head and neck, breast, digestive and gynecological
tumors. There is growing interest in combination of radioimmunotherapy and hy-
perthermia, too.
Material and methods: Heating of the right forelimb was performed with a local
microwave applicator (Erbotherm 240, Erbe, Germany) in 3 Beagles and 30 min-
utes of heat before the start of 3-phase scintigraphy with 300 MBq of 99mTc-MDP.
Another 3 dogs were heated for an additional 30 minutes (Group B-total 60 min.
heat) or 1 hour (Group C-total 90 min. heat) after the start of scintigraphy. The
regional uptakes compared to the contralateral side were calculated with the ROI-
method on the images. Temperature monitoring of 4 points in the right limb was
performed with a newly developed fiber optic laser Bragg-grating thermometry sys-
tem (EC-JRC, Ispra, Italy).
Results: Temperature was constantly 42oC in the center of the heated region and
remained normal at the contralateral side. Uptake of MDP was increased by heat in
Group A with 50% in the perfusion phase, 20% in the tissue phase and 14% in the
bone phase. These values in Group B were 55–42–33%, in Group C: 60–55–75%.
Discussion: Local heating of the dog forearm definitely increases perfusion.
A marked increase could be detected in both the tissue and the bone phase as well.
The increase in uptake of the bone phase can also be due to a kinetic acceleration
of the chemisorption reaction. Based on these results, a significant increase in the
local dose will be available with palliative bone-seeking therapeutic radiopharma-
ceuticals during a combination with local hyperthermia at the site of metastases.
LEAKAGE STUDIES AFTER INTRAARTICULAR INJECTION
OF 90Y AND 169ER RADIOCOLLOIDS IN THE HEALTHY RABBIT KNEE
D. Máthé, A. Polyák, L. Balogh, R. Király, L. Kõrösy, G. Kocsy, A. Kerekes, G.A. Jánoki
”F.J.” National Center of Health, National „F.J.C.” Research Institute for
Radiobiology and Radiohygiene, Budapest
Background: Leakage of radioactivity after intra-articular injection into the knee
joint has been studied in healthy rabbit knee joints. Three colloidal systems have
been studied, 90Y citrate, 90Y silicate and 169Er citrate.
Material and methods: Leakage studies have been performed at various times
post injection with 6 male animals per time point for all preparations. Time points
ranged from 6h to 5 days for the 90Y preparations and 6h to 19 days for 169Er. Knee
joint injection was done with 100–500 µCi of activity in 100 µl volume. Correctness
of injection was checked in all animals by gamma camera with the use of 99mTc-
colloids as well. In some studies, leakages of immobilized and non immobilized
rabbit knees were also compared. The remaining activities in the knees were deter-
mined by measuring bremsttrahlung in a NaI(Tl) scintillation counter. Absorbed ra-
diation dose was calculated using the MIRDOSE 3 software.
Results: Radiocolloids showed a retention of more than 90% from 6 h–2 days, while
the time points up to 5 days indicated a leakage of not more than 10%, with an
exception of the 90Y silicate with a leakage of 16%. Later time points showed
a leakage in the range of 15% for the 169Er colloid. There was no significant differ-
ence between the leakage of immobilized and non immobilized rabbit knees.
Discussion: This extensive study has shown that all preparations reside mostly in
the knee. The estimated radiation burden to other organs is negligible after intraar-
ticular injection of  these radiocolloids. The loss of difference between immobilized
and non-immobilized animals can be a characteristic of the chosen rabbit model.
SUCCESSFULL TREATMENT OF A CANINE THYROID CARCINOMA
WITH THORACAL METASTASES
J. Thuróczy, L. Balogh, É. Balogh, T. Németh, A. Arany-Tóth, E. Perge,
P. Vajdovich, A. Polyák, R. Király, D. Máthé, G.A. Jánoki
Szt. István University, Faculty of Veterinary Science
Department of Gynaecology and Reproduction, Budapest
Operation combined with high-dose radioactive iodine was used in the treatment of
a nine year old, large sized, mixed-breed, male dog with hyperthyroidism resulting
from a large unilateral thyroid carcinoma with multiple thoracal metastases. Hyper-
thyroidism was diagnosed on the basis of clinical signs (lethargy, weight loss, ta-
chycardia, PD/PU) and high basal serum thyroxin (T4) concentrations, as well as
99mTc-pertechnetate scintigraphy that showed a high radiotracer uptake into the
thyroid tumour and thoracal metastases. The fine needle biopsy and the histopatho-
logical examination of the removed primary tumour revealed a compact cell carci-
noma originated from the left thyroid lobe. Ten days after removing the primary
tumour 4.2 GBq I-131 was applied intravenously. After the high dose radioiodine
treatment the dog had been hospitalized for 30 days, T4, haematology, complete
blood chemistry and whole-body scans were made every third day. Radioactivity of
blood and urine samples and the external body surface doses were checked in the
same time as well. The high dose radioiodine treatment resulted a complete abla-
tion of the contra-lateral healthy thyroid lobe and the thoracal metastases. Six, 12
and 18 month after the treatment control laboratory and scintigraphical examina-
tions were carried out and the dog is considered to be tumour-free with a hypothy-
roid status, it only needed daily thyroxin substitution. The dog was euthanized on
the request of the owner 20 month after completing the therapy and  de-compen-
sated cardiac insufficiency with no evidence of tumour abscence was found in
necropsy.
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PREPARATION OF 99M TC LABELLED RECEPTORSSPECIFIC
LIPOSOMES AND LIPOPROTEIN MACROMOLECULES FOR THE
SCINTIGRAPHIC  DETECTION OF THE PLAQES OF ATHEROSCLEROSIS
Z. Bozóky, L. Balogh, D. Máthé, G. Jánoki
“F.J.” National Center of Public Health — “F.J.C.” National Research Institute
for Radiobiology and Radiohygiene
Background: We have used the radiolabelled low density lipoproteins (LDL)and
radiolabelled LDL mimic liposomes for the scintigraphyc detection of plaques in
animal model.
Material and methods: We have isolated lipoproteins by preparative ultracentrifu-
gation. The identification of the heterogeneity of lipoproteins subfractions were ta-
ken for Schlieren analysis. Liposomes were obtained from lipoproteins and from
phospholipids and cholesterol with similar features to lipoproteins. Radiolabelling
of lipoproteins and liposomes with 99mTc were performed using sodium dithionite
as a reducing agent. Radiochemical purity and in vitro stability of radiolabelled com-
ponents were controlled by paper chromatography. Rabbits fed a diet containing
1% cholesterol for 60 days to develop hyperlipidemia and atheromatous aortic
plaques. Gamma scintillation camera imaging of the rabbits were performed for
radiolabelled lipoproteins, and  liposomes.
Results: The analytical and preparative ultracentrifugation  methods proved to be
useful to obtain lipoprotein aliquots for radiolabeling. Labelling efficiencies were
more than –90% for lipoproteins and liposomes. Mean uptake of 99m Tc-labelled
lipoproteins and liposomes in the aorta (mainly in aorta arch) and in caroted arteries
were higher in hypercholesterolemic rabbits than in normal rabbit controls (about 3
fold qauntity increased uptake), which were confirmed by pahtological examina-
tions.
Conclusions: Our preliminary results showed that gamma camera in vivo scintigra-
phy of rabbits revealed visible signal corresponding to atherosclerotic plaques by
radiolabelled lipoprotens and liposomes. Liposomes can be made from lipids which
closely mimic the metabolic behaviour and receptor binding features of lipopro-
teins.
RADIOPHARMACY
MEASUREMENTS OF COLLOID PARTICLE SIZE IN THERAPEUTICAL
RADIOPHARMACEUTICALS
A. Polyák, L. Balogh, D. Máthé, G.A. Jánoki
”F.J.” National Center of Health, National „F.J.C.” Research Institute for
Radiobiology and Radiohygiene, Budapest
Background: Localization and pharmacokinetics of therapeutical colloid radio-
pharmaceuticals mainly depends on their particle sizes. In our experiments we used
laser scattering method for determination the sizes of different colloids. Samples
tested were 90Y-Citrate, 90Y-Silicate, 166Ho-Fytate and 188Re-(Tin-) colloid.
Material and methods: The analytical instrument used in our experiments named
DynaPro is a product of the Proteinsolutions Inc. The sample is illuminated by
a semi-conductor laser of ~830 nm wavelength. The DynaPro analyses the time
scale of the scattered light intensity fluctuations by a mathematical process. The
hydrodynamic radius of the sample is determined using the Stokes-Einstein equa-
tion. In our experiments paralelly with the samples calibration standard was mea-
sured, it was 160 nm polystyrene standard (Bangs Laboratories Inc., Serial NO:
5692). Radiochemical stability measurements were in different time points by TLC.
Results: The calibration found more than 95% exactness of the standard
measurements.Particle fraction of 90Y-Citrate colloid ranged between 1 and 7 µm
(mean diameter: 3.5 µm) and in case of 90Y-Silicate colloid particles ranged be-
tween 0.1 and 4.5 µm (mean diameter: 1 µm). 188Re-(Tin-)Colloid mean diameter
was around 4.5 µm. We also examined the stability of the colloid products. These
radiopharmaceuticals showed high particle and radiochemical stability (> 99%) in
vitro and in synovial fluid.
Conclusion: Because of pharmacokinetics of therapeutical radiocolloids depends
on their particle sizes the measurements by laser scattering method can be a very
important element of radiopharmaceutical research.
RADIOLABELLING OF SOMATOSTATIN ANALOGUE PEPTIDES BY 90Y
A. Polyák, L. Balogh, D. Máthé, G.A. Jánoki
“F.J.” National Center of Public Health — “F.J.C.” National Research Institute for
Radiobiology and Radiohygiene
Background: In the therapy of somatostatin expessing tumours by therapeutical
radiopharmaceutical a somatostatin analogue peptid is radiolabelled by beta-emit-
ter radionuclide. In our experiments it was 90Y.
Material and methods: 90Y radionuclide was as [90Y]Yttriumcloride in aqueous so-
lution (0.04M HCl) with 99.9% radiochemical purity (manufactured by AEA Technol-
ogy QSA GmbH, Braunschweig, Germany). The labelled peptide product were DOTA-
-TOC (maufactured by Kantonsspital, Basel and IEO, Milano) and DOTA-TATE
(piCHEM, Graz).
Before labelling petide was dissolved in milliQ destillated water and gentisic-acid
with sodium-acetate buffer (pH:5) was added into the solution as a free radical
scavenger. Incubation was at 90æC for 30 minutes.
For quality control we used several processes paralelly. To separation we used
reverse phase chromatographic cloumns (Supelco C-18, Merck RP-18, Sep-Pak
Cartridges C-18), thin layer chomatography (TLC — 0.1M sodium-citrate solution;
ITLC — 40 mM DTPA solution) and HPLC. To measure sample activity CAPINTEC
CRC 15 beta (Capintec Inc., USA) dose calibrator and well-type gamma counter
were used. In vitro radiochemical stability of labelled compounds was tested with
incubaion in saline and sera for different times.
Results: Labelling efficiency of 90Y-peptides was 99%. We showed in the stability
measurements that labelled peptide shows high radiochemical stability in saline
and also in blood sera. The main concern of labelling is the absence of free metal
ions (mostly Fe3+ és Zn2+) in the micro reaction space and the exact masurement of
small beta activities.
Conclusion: Radiolabelling of somatostatin analogues by beta-emitter radionucli-
des allows of produce new terapeutical radiopharmaticals.
RADIONUCLIDE RELEASES FROM THE SEMMELWEIS UNIVERSITY
CLINIC OF RADIOLOGY AND ONCO-THERAPY TO THE ENVIRONMENT
AND THE LIMITS
L. Duffek, B. Kanyár, T. Györke, E. Makó
Department of Diagnostic Radiology and Oncotherapy, Semmelweis University,
Faculty of Medicine, Budapest Radiation Protection Service, Semmelweis
University, Budapest
During the last years the annually used unsealed radionuclide activities in the Clinic
are the following: 99mTc: 1500 GBq to renal diagnostics and 1500 GBq to bone
diagnostics, 153Sm: 35 GBq in bone therapy and 131I: 3 GBq in thyroid therapy. To
assess the discharges into the aquatic environment it is assumed that the whole
activity applied in renal tests removed by the urine of the patients directly into the
waste water, while for the bone tests only the 40%. The amount of discharged 153Sm
takes 40% of the total used one and for 131I 20% during the staying of the patients
inside the Clinic. The atmospheric releases are assessed by 1% of the total activi-
ties of 99mTc and 131I and 0.1% of 153Sm.   Taken into consideration the regulations
issued at 6. June, 2001 by the Ministry of Environmental Protection as Authority the
assessed releases in 2004 are the following: to the aquatic environment 8% and to
the atmospheric pathway 38% of the proper limits. The last one is over the investi-
gation level therefore a more detailed assessment procedure is to be provided and
depending on the improved results protection actions have to be introduced. The
main contribution to the decision function both in aquatic and atmospheric path-
ways can be derived from the radionuclide 99mTc. Probably the uncertainty of the
assessment is high mainly due to the short half life of the 99mTc.
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TRANSMISSION OF BACKGROUND RADIATION DATA TO NATIONAL
RADIATION MONITORING SYSTEM (OSJER) VIA INTERNET
O. Gyuris1, L. Almási1, 2, T. Séra1, 3, T. Neszt3, L. Pávics1, 3
1International Medical Centre, Szeged
2University of Szeged Department of Medical Informatics
3Department of Nuclear Medicine
Our Institute joined the OSJER in 1997. During the past years we have purchased
2 high sensitivity proportional gamma detectors, BITT RS/03 (BITT Technology),
enabling indications of minor changes in the ambient natural radioactivity level. These
gammameters were connected to a personal computer. At an early stage we man-
ually downloaded the measurements data and converted them into Excel file and
then we e-mailed this file to the Information Centre (BIK), weekly.
The aim of our work was to automate the measurement, data transfer and visuali-
tion by means of a server computer connected to Internet. The parameters of the
installed server were: 400 Mhz CPU, 32 MB RAM, 80 GB hdd, Debian GNU Linux
operation system, Apache WEB server, MRTG diagram maker, Rsync fast remote
file copy program - free softwares. The measurements of the sensor are obtained
via serial port by means of a special software. The data are downloaded, stored
locally and transported to the BIK by 5 minutes. At the same time diagrams are
made in daily, weekly, monthly and yearly splitting. The diagrams are archived daily
available on the http://tio.numed.szote.u-szeged.hu/ website. It is possible to get
the last measured data from mobile telephone from the
http://tio.numed.szote.u-szeged.hu/wap/ site.
RADIATION SAFETY RELATED TO THE OUTPATIENT
RADIOIODINE THERAPY
T. Sera1, 2, 3, M. Papos2, 3, A. Kerekes4, S. Szakacs4, M. Lazar2, 3, S. Pellet4,
L. Kardos3, J. Julesz1, L. Pavics2, 3
University of Szeged:
1Department of Endocrinology
2Department of Nuclear Medicine
3International Medical Centre, Szeged
4National Research Institute for Radiobiology and Radiohygiene, Budapest
Aim: The aim of this study was to investigate the external and internal doses of the
husband (45 years) and daughter (15 years) of a woman (38 years) with thyroid
autonomy treated with 170 MBq of I-131.
Material and methods: The background dose rate variation was determined using
a sensitive proportional counter, the personal doses were measured with electronic
dosimeters. The internal doses were estimated via the radioiodine concentration in
samples taken with an air sampler equipped with a charcoal cartridge and aerosol
filter, using a HPGe detector.
Results: The average natural background dose in the house before treatment was
(mean ± SD) 2.2 ± 0.3. After the treatment, the background was 28 microSv for the
first 24 hours, which decreased to 3.8 microSv by day 11. The total integrated dose
for the 11 days was 170 microSv. The personal dosimeters showed a total of
46 microSv (maximum 6 microSv on day 3) for the husband and 40 microSv (ma-
ximum 7 microSv on day 5) for the daughter. The internal doses were estimated as
57 microSv (husband) and 80 microSv (daughter), based on a time-integrated
I-131 activity concentration of 130 Bq/m3d.
Conclusion: The total dose of each of the family members was well below the re-
commended levels of 3 mSv and 1 mSv respectively, and a higher administered
I-131 activity would also yield acceptable personal doses. In contrast with our ex-
pectations, the personal dosimeters of the family members did not show the hi-
ghest values on day 1, probably because of a decrease in self-protection against
the radiation. This should be mentioned while informing patients.
ROLE OF LOCAL AND REGIONAL MONITORING SYSTEMS IN HEALTH
PHYSICS ASSESSMENT OF RADIATION INCIDENTS AND ACCIDENTS
P. Zagyvai1, T. Bujtás2, B. Kári3
1Budapest University of Technology and Economics, Institute of Nuclear Techn.
2NPP Paks
3Semmelweis University, Department of Diagnostic Radiology and Oncotherapy,
Budapest
 In April 2003 a severe incident took place at Unit #2 of NPP Paks during the tempo-
rary surface cleaning of a group of current fuel bundles that led to the break of fuel
bundles and the subsequent radiocontamination of local storage tanks. Members
of the operating personnel suffered a dose exposure that was well below the limit of
harmful consequences but exceeded the normal operational level. The planning of
the compound technological procedure for the removal of the broken fuel bundles
should consider the potential increase of dose exposure as well. In order to provide
a complete assessment for these situations both local (on-site) and environmental
(off-site) monitoring should be performed in addition to personal dose measure-
ments including the measurement of external dose rate and radionuclide emission.
We will present the various data categories that can be provided by local and envi-
ronmental monitoring systems, giving special emphasis to continuous health phy-
sics assessment during the process of broken fuel removal and the comparison of
sensitivity of appropriate methods of on-site and off-site monitoring.
ROLE OF THE PACS IN THE MULTI-MODALITY
NON-INVASIVE IMAGING DIAGNOSTICS AND RESEARCH
B. Kári1, Z. Gyõfi2, B. Mihalik3, Z. Hegyi4, Á. Mester1,
T. Gyöke1, Z. Dömötöri1, E.K. Makó1
1Semmelweis University, Faculty of Medicine, Department of Diagn. Radiology
and Oncotherapy Budapest
2Kepdoktor Ltd.(eRAD ImageMedical Hu)
3Mihalik-Dovak Ltd.
4MEDISO Ltd. Budapest
More and more efficient utilization of the rapidly growing novel results and possibi-
lities to be produced by the non-invasive digital imaging systems in clinical applica-
tion and the related research and developing works are the serious challenges of
nowadays. Technological background is provided by the electronic archival system
of digital imaging modalities -PACS- with the communication structures.
Due to the research and developing activities in our department (supported by
3 domestic companies) a PACS system with the communication architecture have
been created and then integrated into the daily clinical application as well as the
research, development and education. Three modalities — CT, NM, VIDAR X-ray
film scanner (mainly for mammography) — are connected to the PACS by on-line
DICOM 3.0 communication (PracticeBuilder1-2-3® and MEDISA), while the other
2 modalities (RAD-850 film scanner and ACUSON ultrasound) by off-line DICOM
way with HUG-Osiris software support. Simultaneous presentation of multi-modal-
ity images, tele-conference and the electronic archival play significant role in the
routine clinical work. PACS based multi-modality is an essential condition for our
following research activities like: digital image processing, small animal experiments,
quantitative evaluation of digitized mammography and construction of advisory lev-
el database as well as pattern recognition. Fusion between various image modali-
ties is already the main power of the future non-invasive diagnostics.
Due to the MEDISO Ltd. supports our department develops the necessary techno-
logical conditions for clinical introduction of a cost-effective image fusion software
system -Pmod (Univ. Zürich)-.
The achieved results of our research on PACS field highly contribute to do the
non-invasive imaging diagnostics even more efficiently.
INSTRUMENTATION
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INTERVIEW XP™ IS A WINDOWS®XP BASED GENERAL PURPOSE
IMAGE PROCESSING SYSTEM FOR NUCLEAR MEDICINE
B. Kári1, J. Varga2, A. Farkas3, L. Nagy3, J. Turák3, F. Kovács4,
J. Östör3, T. Györke1, O. Pártos5
1Semmelweis University Faculty of Medicine, Department of Diagn. Radiology
and Oncotherapy, Budapest
2University of Debrecen, Department of Nuclear Medicine
3MEDISO Ltd.
4Uzsoki Hospital, Budapest Department. of Nuclear Medicine
5Gottsegen György Hungarian Institute of Cardiology, Department of Isotope
Diagn., Budapest
InterView XP™ is a graphical based nuclear medical image processing system for
both planar and SPECT studies developed by MEDISO Ltd. The evaluation system
was dedicated mainly for the domestic developed and manufactured nuclear me-
dical imaging systems keeping under consideration the connectivity to other equip-
ments and workstations. The evaluation system is Windows®XP based on PC plat-
form (P4 CPU is highly recommended). The minimum requirements for the display-
ing system are to support the 1280 × 1024 resolution with 16bit depth. The funda-
mental database format is still DIAG, but DICOM 3.0 based structure is on the test
phase already. The compatibility is supported between the two database struc-
tures. System management of  InterView XP™ is very similar to InterView™. It is
graphical, object oriented, interactive and easy to learn due to the well arranged
and logical linked objects. The daily routine procedures can be pre-defined by or-
gan specific according to the acquisition techniques. But they are interactively mod-
ifiable during the processing procedure when the needs arise. All users can create
and save own final result pages and hardcopy document outlines according to the
demands. Design and creation of the result pages and documents are supported
by pre-defined object set called templates.  The results produced by InterView XP™
can be compared and validated by both domestic (Pegasys, microSEGAMSa, DIAG)
and international (Pegasys, SEGAMI, HERMES, …) references due to the DICOM 3.0
and Interfile 3.31 communication.
EXPERIENCE WITH DICOM BASE MULTIMODALITY MEDICAL IMAGE
PROCESSING AT THE PET CENTER OF THE UNIVERSITY OF DEBRECEN
G. Opposits1, M. Emri1, P. Barsi2, P. Bogner3, O. Ésik4, J. Julow5,
M. Kiss6, J. Kollár7, J. Martos8, L. Trón1, 9
1PET Center, University of Debrecen Medical and Health Science Center
2National Institute of Psychiatry & Neurology, Department of Radiology, Budapest
3University of Kaposvár, Diagnostic Institute
4University of Pécs, Department of Oncotherapy
5St. Johns Hospital, Department of Neurosurgery, Budapest
6Huniko Kft., Nyíregyháza
7Radiological Clinics, University of Debrecen Medical and Health Science Center
8National Institute of Neurosurgery, Budapest
9PET Research Group of Hungarian Academy of Sciences
Background: Digital radiology ensures the possibility to process images recorded
by different modalities in the same way and transmit them via the internet. This
intention is facilitated by DICOM standard whose implementations may be very
different.
Material and methods: To overcome the problems arising from this variegation,
we decided to supplement the software library developed at our department with
a DICOM implementation. This allows for the identical data procession of files from
national and international partners alike.
Results: We routinely use CT and MRI data files in daily diagnostics as well as in the
spatial standardization of brain activation examinations. Images and contours are
transmitted in DICOM format to support the planning of irradiation. After the spring
of 2005, all of the Debrecen patients will be given their PET images in DICOM for-
mat.
Conclusion: We have been given an opportunity to start methodological develo-
pment in the field of cardiological image processing through the wider implementa-
tion of DICOM standard.
ADAPTIVE FILTERING PROCEDURE TO EHANCE HIGHER
LUMINOSITY OBJECTS IN NUCLEAR MEDICAL IMAGES
1S.K. Al-Arbi, 1L. Balázs, 2B. Kári,
1P. Zagyvai, 1Budapest University of Technology and Economics, Institute
of Nuclear Techn.
2Semmelweis University Department of Diagnostic Radiology and Oncotherapy,
Budapest
The current image processing work deal with a special nuclear medicine problem,
when it is necessary to detect and display within a relatively high activity territory
(high luminosity) even higher activity defects (hot nodule) with better and better
efficiency i.e. in earlier and earlier phase (e.g. hot nodule metastases in spine or in
sacrum). The most often applied noise filtering procedures in routine daily image
processing — besides the noise reduction — reduces the image contrast in the
sudden changes environment, consequently the enhancement of higher activity i.e.
the higher luminosity objects in noisy environment demands edge or contrast pre-
serving filtering method. But this is not optimal within the stationer region, which
surrounds the enhancing object. An adaptive convolution filtering procedure (filte-
ring series) for 2D scintigraphy images have been worked out to avoid the above
mentioned problem. The filter identifies the local significant changes in the first step
and then according to the determined contrast function will be selected the way of
filtering with the filter parameters in order to optimize the noise elimination for better
enhancement of the target object.   The filter properties have been tested by phan-
tom images particularly on the directional and pattern sensitivity, contrast sensitiv-
ity, detection limit and the sensitivity of the transition zone. The influence of the
different noise level was under consideration too at the tests. The image processing
procedure has been applied for various human cases also with promising results.
Further refinements are necessary in the current optimization algorithm in order to
reduce the image artifacts produced by adaptive filtering.
CLUSTER BASED PET AND SPECT RECONSTRUCTION
SOFTWARE LIBRARY
I. Valastyán1, M. Emri1, L. Balkay1, S. Kis1, G. Molnár1, G. Opposits1,
J. Molnár2, D. Novák2, I. Bagaméry3, L. Trón 1, 4
1PET Center, University of Debrecen Medical and Health Science Center
2Institute of Nuclear Research, Hungarian Academy of Sciences
3Mediso Ltd.
4PET Research Group of Hungarian Academy of Sciences
Background: Iterative reconstruction methods of the PET and SPECT technique
produce high resolution and good signal-noise ratio images. There are a lot of algo-
rithms in the literature, which assume high computational capacity, and they give
better quality images than routinely used algorithms do.
Material and methods: We aimed at developing a software library which contains
the conventional and new reconstruction methods and is good for data acquisition
simulation.  Our library is easy to adapt for different topological detector systems.
Results: The available algorithms are the 2D and 3D filtered back projection, MLEM
and OSEM based on one pre-generated high precision system matrix. The current
version of the software library allows for studying the effects of matrices generated
in different ways. The cluster based implementation enables the studies of the par-
allelization of calculation procedures. The programs based on this library were test-
ed on data acquired by our small animal PET camera.
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EFFICACY OF RADIOIODINE THERAPY IN ELDERLY PATIENTS
WITH DIFFERENT TYPES OF HYPERTHYROIDISM
A. Czarnywojtek1, R. Czepczyński1, I. Warmuz-Stangierska1, W. Herman2,
A. Wyszomirska1, J. Sowiński1
1Department of Endocrinology and Metabolism, Poznań University of Medical
Sciences, Poznan, Poland
2Outpatient Clinic of Endocrinology, Wschowa, Poland
Background: The number of elderly patients treated with radioiodine in our centre
is increasing. The effectiveness of radioiodine therapy (RIT) in elderly patients with
different types of hyperthyroidism (toxic nodular goiter, Graves’ disease and toxic
adenoma) was the objective of this study.
Material and methods: We analyzed the effect of RIT in 536 patients, aged 60–91 years
(mean: 68.7± 8.2; median: 66 years) treated for hyperthyroidism. We studied
a group of 451 women (84.1%, age 75.0 ± 12.3 years) and 85 men (15.9%; age
62.8 ± 4.9 years) treated between October 2002 and October 2003. The doses of
131I ranged from 3.0 to 22.0 mCi. The effect of RIT was prospectively studied for one year.
Results: Etiology of hyperthyroidism was as follows: toxic nodular goiter (n = 453;
84.5%), Graves’ disease (n = 53, 9.9%), toxic adenoma (n = 21, 3.9%) and iatro-
genic thyrotoxicosis in 9 patients (1.7%). Twenty-six (5.0%) of patients had been
diagnosed in the last 3 months, 332 (61.9%) in the last 2 years, 81 (15.1%) in the last
5 years, 53 (9.9%) in the last 10 years, and 42 (7.9%) in the last 20 years.
In the studied population, one year after RIT, hypothyroidism occured in 132 pa-
tients (24.6%), normal hormonal status was found in 339 patients (63.2%) and hy-
perthyroidism was observed in 65 patients (12.1%).
In the group of patients with toxic nodular goiter, 116 (25.6%) patients developed
hypothyroidism, 278 (61.4%) were euthyroid, and 59 (13.0%) had recurrence of
hyperthyroidism. The respective numbers in the group of Graves’ disease were:
10 (18.9%), 38 (71.7%) and 5 (9.4%). In the group of patients with toxic adenoma:
3 (14.3%), 18 (85.7%) and 0 (0%) and in the group of iatrogenic thyrotoxicosis (after
amiodarone): 3 (33.3%), 5 (55.6%) and 1 (11.1%).
Conclusions: RIT is safe and effective in the treatment of hyperthyroidism in elderly
patients. The most common indication for RIT was toxic nodular goiter. The best
efficacy of RIT was found in patients with toxic adenoma. The highest incidence of
hyperthyroidism recurrence was observed in patients with toxic nodular goiter.
THE RISK OF NOT DIAGNOSED MALIGNANCY IN PATIENTS WITH
TOXIC MULTINODULAR GOITER WHO HAD BEEN QUALIFIED FOR I-131
TREATMENT
A. Kowalska, I. Pałyga, D. Gąsior-Perczak, E. Mikina, J. Słuszniak, J. Paszkiewicz,
J. Sygut
Endocrinology Department, Hollycross Cancer Centre, Kielce
Background: I-131 treatment of patients with hyperthyroidism is contraindicated in
case of thyroid cancer. The objective of the diagnostic work-up before I-131 treat-
ment is to exclude malignant nodules in the thyroid.The most effective test for diag-
nosis of malignancy is ultrasound-guided fine-needle aspiration cytology (FNAC).
FNAC has a specificity and sensitivity of approximating 95%, however the negative
result of FNAC cannot exclude malignancy. Thyroid cancer has been revealed in
histopathological material in 4 of 200 cases of patients who had been operated on
multinodular goiter in ŚCO in 2000, although preoperative complete diagnostic work-
up had excluded malignancy.
Aim: The purpose of our study was to evaluate the risk of not diagnosed malignancy in
patients with toxic multinodular goiter who had been qualified for I-131 treatment.
Material and methods: The study involved 260 patients with toxic multinodular
goiter, treated with I-131 in years 1999–2000. Diagnostic work-up before treatment
included  thyroid ultrasonography and FNAC of every suspicious of malignancy
lesions (hypoechoic, with absence of a periferial halo, irregular margins, micro cal-
cifications or hypervascularisation at Doppler ultrasonography and every clinical
thyroid nodules). Thyroid cancer was excluded in every patient before I-131 treat-
ment. After the treatment long-term follow up of patients was performed. Once
a year thyroid ultrasonography was performed and also FNAC- in case of any en-
largement of the lesion or clinically suspicious tumour. Patients with positive result
of FNAC or with progression of tumour (up to 100%) were operated.
Results: Among 260 followed up patients — 26 (10%) — had developed enlarge-
ment of thyroid nodule. These patients were submitted to FNAC. Diagnosis of folli-
cular neoplasm was revealed in one patient, and multinodular goiter in 25 patients.
Eventually two patients were sent to operation — one with enlargement of the thy-
roid nodule up to 100%, and the second one with diagnosis of follicular neoplasm.
Histopathological examination in both cases did not reveal malignancy. Moreover
no patient has developed thyroid cancer during 4-year-follow-up.
Conclusion: Diagnostic work-up protocol employed in ŚCO in case of patients with
toxic multinodular goiter qualified for I-131- therapy, allows reducing the risk of not
diagnosed malignancy before treatment. Taking into consideration false negative
results (4/200) of thyroid cancer in case of patients who underwent operations,
nearly the same amount of not diagnose thyroid cancer should be expected among
patients treated with I-131 that commands further control of the patients from the
viewpoint of cancer detection.
EFFICACY OF RADIOIODINE THERAPY OF LARGE
MULTINODULAR GOITER
M. Bączyk, M. Pisarek, M. Gryczyńska, K. Ziemnicka, P. Gut, J. Sowiński
Department of Endocrinology, Metabolism and Internal Diseases, University
of Medical Sciences, Poznań, Poland
The efficacy of fractionated radioiodine therapy in patients with multinodular large
goiter was assessed in the present study. Therapy was undertaken in patients dis-
qualified from surgery due to high risk or in patient who gave no consent to surgery.
Studies were performed in 24 women (age range: 62–82 yrs) with large goiters (II° in
WHO classification and goiter volume assessed over 100 ml assessed by ultra-
sound).
Serum TSH, fT4, antithyroid antibodies (anti-TPO, anti-Tg, TSHR-Ab) levels were
estimated in all patients. Radioiodine uptake test (after 5 and 24 hours), 131-I thy-
roid scintigraphy and fine needle biopsy to exclude neoplasmatic transformation
were also performed. No malignant nodules were detected.
During classification to the therapy in 18 patients hyperthyroidism and in 6 patients
normal thyroid function was diagnosed. All the tests and subsequent radioiodine
therapy were repeated every 3 months. The cumulative dose of 4.44 GBq (120 mCi)
was administered over 12 months (30 mCi every 3 months).
Before therapy, the mean thyroid volume was 163 ml (range: 100–370 ml; median
145 ml). It gradually decreased to 123 ml (range: 56–240 ml; median 109 ml) after
6 months and to 110 ml (range: 49–213 ml; median 90 ml) after 12 months. After
12 months: 62% of patients were euthyroid, 8% of patients were hyperthyroid and
30% of patients turned hypothyroid. Anti-TPO and anti-Tg antibodies showed ten-
dency to rise, with significant differences and fluctuations in particular patients (aTPO
— median: 30 IU/ml to 58 IU/ml; anti-Tg — median: 31 IU/ml to 44 IU/ml).
The fractionated radioiodine therapy is safe and effective method of treatment of
large multinodular toxic goiter. During these observations we found no correlation
between the levels of antithyroid antibodies, radioiodine uptake and reduction of
goiter volume.
EVALUATION OF DNA DAMAGE AND REPAIR IN AUTONOMOUS
THYROID NODULES AND PERIPHERAL BLOOD LYMPHOCYTES
IN PATIENTS RECEIVING 131-IODINE THERAPY
W. Grzesiuk1,  J. Nieminuszczy2, M.T. Płazińska3, M. Bogdańska4,
M. Kruszewski5, L. Królicki3, E. Bar-Andziak1, E. Grzesiuk2
1Department of Internal Medicine and Endocrinology, Medical University,
Warszawa, Poland
2Department of Molecular Biology, Institute of Biochemistry and Biophysics PAS,
Warszawa, Poland
3 Department of Nuclear Medicine, Medical University, Warszawa, Poland
4 Department of Pathology, Medical University , Warszawa, Poland
5Department of Radiobiology and Health Protect, Institute of  Nuclear Chemistry
and Technology, Warszawa, Poland
Background: Radioiodine treatement of patients with autonomous thyroid nodule
leads to cellular DNA damage not only in thyreocytes but also in peripheral blood
lymphocytes (PBL). Damage to DNA induces DNA repair systems thus eliminating
these damages.
Aim: The purpose of this study was to evaluate DNA breakage and base damage with
the use of comet assay in thyreocytes  and PBL in patients treated with 131-Iodine.
Material and methods: In all the patients thyroid scintigram showed a single “hot
nodule”. Damage to DNA was estimated by comet assay in thyreocytes taken from
“hot nodule” by fine needle aspiratory biopsy and in PBL. Samples were taken
three times: before radioiodine treatment, and 12 and 54 days after.
Results: Preliminary results indicate a high diversity in the level of DNA damage
among the patients. In lymphocytes 12 days after 131-I application a significant
level of DNA breakage and base damage was still observed. However, after
54 days the level of DNA damage in lymphocytes was even lower than in the con-
trol. In contrast, in “hot nodule” cells DNA damage persisted until the 54th day after
131-I treatment. Differences in the type of damage between thyroid cells and lym-
phocytes were also observed. In lymphocytes there was more base damage while
in thyreocytes  single strand DNA breaks prevailed.
Conclusion: The comet assay can be a valuable tool for monitoring radioiodine
treated patients. The differences in the type and persistence of DNA damage in
lymphocytes and thyreocytes might indicate different mechanisms of DNA damage
induction and/or differences in DNA repair mechanisms.
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GRAVES’ OPHTALMOPATHY AFTER RADIOIODINE TREATMENT
— REVIEW OF SEVEN YEARS EXPERIENCE
M.H. Listewnik, B. Birkenfeld, G. Kulig, K. Pilarska
Pomeranian Medical University, Szczecin, Poland:
1Department of Nuclear Medicine
2Department of Endocrinology
Background: The relationship between Graves’ ophtalmopathy (GO) and radioac-
tive iodine (RAI) treatment of Graves’ disease is still a matter of controversy. The aim
of the study is to establish the rate of this complication and analyse the factors
which may interfere.
Material and methods: A retrospective analysis of patients data emphasising those
with Graves’ hyperthyroidism receiving RAI from 1998 to October 2004 was done.
Results: The total number of 3459 patients were treated according to Marinelli’s
formula with RAI. Among them nearly 700 suffered from Graves« disease. After RAI
7 patients developed severe form of GO and were qualified for specific treatment at
the department of endocrinology. The patients data are gathered in the Table:
Pt/ Age Thyroid Absorbed   Thyroid Time Ophtalm. Ophtalm. I.v pulses Rtg-
No/ (years) Volume dose function (years) Index Index of therapy
Sex   before (Gy) one year interval according according methyl-
RAI [ml] after RAI    between to to -predni-
RAI and GO Donaldson Donaldson -solone
1. F 70 140 200 Hyperthyroidism 2 1 4 V courses YES
2. M 69 28 150 Hypothyroidism 4 4 5 I course NO
3. F 53 35 250 Hypothyroidism 2 2 2 III courses YES
4. F 53 10 150 Hypothyroidism 4 5 3 VI courses YES
5. F 63 35 200 Hypothyroidism 1 3 4 IV courses YES
6. M 57 25 120 Normal 1 0 3 NO YES
7. F 50 25 120 Hypothyroidism 5/12 3 4 III courses NO
Conclusions: RAI because of Graves’ hyperthyroidism  is given to nearly one hun-
dred patients per year at our department but severe GO occurred only at about 1%
of treated patients. According to our data GO is not so often encountered compli-
cation after RAI. Hypothyroidism after RAI may increase the GO rate.
